| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SOX5 ZNF384 SP1 SP2 SP3 SP4 SALL3 ZNF274 ZNF236 FOXD4L5 DHX9 BPTF FOXD4L4 NFYA NFYC MED12 NPAS2 ZBTB33 RELA POU6F1 CREB1 CREM TFDP1 PASD1 PKNOX2 FOXP4 ARNT MTOR ZNF335 CARF GMEB1 ZNF76 ATF1 NFAT5 ZSCAN23 | 4.95e-08 | 1271 | 201 | 35 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SOX5 ZNF384 SP1 SP2 SP3 SP4 SALL3 ZNF274 ZNF236 FOXD4L5 DHX9 BPTF FOXD4L4 NFYA NFYC MED12 NPAS2 ZBTB33 RELA POU6F1 CREB1 CREBBP CREM TFDP1 PASD1 PKNOX2 NCOR1 GTF2A1 FOXP4 ARNT USF3 ZNF335 CARF GMEB1 ZNF76 ATF1 NFAT5 ZSCAN23 | 5.17e-08 | 1459 | 201 | 38 | GO:0000977 |
| GeneOntologyMolecularFunction | transcription factor binding | BDP1 SP1 SP3 KEAP1 KDM5D DHX9 MED24 BPTF NFYA TAF4B MED12 MED29 RELA CREB1 CREBBP CREM TFDP1 PASD1 NCOR1 GTF2A1 ARNT PAXBP1 MTOR ARID2 NFAT5 | 1.69e-07 | 753 | 201 | 25 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SOX5 ZNF384 SP1 SP2 SP3 SP4 SALL3 ZNF274 ZNF236 FOXD4L5 DHX9 BPTF FOXD4L4 NFYA NFYC MED12 NPAS2 ZBTB33 RELA POU6F1 CREB1 CREM PASD1 PKNOX2 FOXP4 ARNT ZNF335 CARF GMEB1 ZNF76 ATF1 NFAT5 ZSCAN23 | 2.99e-07 | 1244 | 201 | 33 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SOX5 ZNF384 SP1 SP2 SP3 SP4 SALL3 ZNF274 ZNF236 FOXD4L5 FOXD4L4 NFYA NFYC NPAS2 ZBTB33 ADNP2 RELA POU6F1 CREB1 CREM TFDP1 PASD1 PKNOX2 FOXP4 ARNT KMT2D USF3 CARF GMEB1 ZNF76 ATF1 NFAT5 ZSCAN23 SP140 | 1.75e-06 | 1412 | 201 | 34 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | SP1 SP3 KEAP1 KDM5D DHX9 MED24 TAF4B MED12 RELA CREB1 CREBBP TFDP1 NCOR1 GTF2A1 ARNT | 2.25e-05 | 417 | 201 | 15 | GO:0061629 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | SP1 SP3 KEAP1 KDM5D DHX9 MED24 TAF4B MED12 RELA CREB1 CREBBP CREM TFDP1 PASD1 NCOR1 GTF2A1 ARNT | 8.79e-05 | 582 | 201 | 17 | GO:0140297 |
| GeneOntologyMolecularFunction | TFIIIC-class transcription factor complex binding | 1.01e-04 | 2 | 201 | 2 | GO:0001156 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 4.63e-04 | 64 | 201 | 5 | GO:0140296 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SP1 CNKSR1 GON4L SUPT20HL2 KEAP1 TRRAP DHX9 MED24 TOLLIP POLK MED12 GTF2A1L ANK1 ANK3 MED29 CREBBP FAN1 HIPK3 NCOR1 IGF2BP2 KMT2D SYNE3 AKAP9 HELZ2 PAWR RIMS2 HERPUD1 | 5.30e-04 | 1356 | 201 | 27 | GO:0060090 |
| GeneOntologyMolecularFunction | RNA polymerase III general transcription initiation factor binding | 5.97e-04 | 4 | 201 | 2 | GO:0001025 | |
| GeneOntologyMolecularFunction | triplex DNA binding | 5.97e-04 | 4 | 201 | 2 | GO:0045142 | |
| GeneOntologyBiologicalProcess | DNA repair | SMG1 UBQLN4 SUPT20HL2 POGZ TRRAP DHX9 NFRKB USP7 HERC2 POLK NPAS2 RAD23A MMS22L DDX12P EP400 CREBBP FAN1 SF3B3 ARID2 FMN2 NHEJ1 RPA2 TOP2B | 9.63e-08 | 648 | 201 | 23 | GO:0006281 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ZNF384 SP1 SP3 GPBP1 SUPT20HL2 POGZ MAP3K1 DHX9 MED24 BPTF NFYA NFYC TAF4B MED12 NPAS2 MED29 RELA CREB1 CREBBP CREM TFDP1 GTF2A1 ARNT KMT2D USF3 PAXBP1 ARID2 ZNF335 CARF HELZ2 GMEB1 ZNF76 ATF1 NFAT5 MAP2K5 | 1.99e-07 | 1390 | 201 | 35 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of DNA repair | UBQLN4 SUPT20HL2 TRRAP DHX9 NFRKB NPAS2 EP400 CREBBP SF3B3 ARID2 FMN2 RPA2 TOP2B | 5.32e-07 | 234 | 201 | 13 | GO:0006282 |
| GeneOntologyBiologicalProcess | DNA damage response | SMG1 UBQLN4 SUPT20HL2 POGZ TRRAP DHX9 NFRKB USP7 RPS6KA6 HERC2 POLK NPAS2 RAD23A MMS22L DDX12P EP400 CREBBP FAN1 SF3B3 MTOR ARID2 FMN2 SPRED1 NHEJ1 NFAT5 RPA2 TOP2B | 7.22e-07 | 959 | 201 | 27 | GO:0006974 |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | ANKRD31 SMG1 UBQLN4 SUPT20HL2 TRRAP DHX9 NFRKB USP7 NPAS2 EP400 CREBBP TFDP1 SF3B3 ARID2 FMN2 ATF1 RPA2 TOP2B | 1.11e-05 | 564 | 201 | 18 | GO:0051052 |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 1.15e-05 | 143 | 201 | 9 | GO:0045739 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | BDP1 ZNF274 POGZ KDM5D TRRAP MED24 BPTF NFRKB USP7 TAF4B MMS22L EP400 MED29 EEF1AKMT3 BAZ2B RELA CREB1 CREBBP PHC1 NCOR1 GTF2A1 KMT2D ARID2 ZNF335 NFAT5 | 1.49e-05 | 999 | 201 | 25 | GO:0071824 |
| GeneOntologyBiologicalProcess | DNA metabolic process | ANKRD31 SMG1 UBQLN4 SUPT20HL2 POGZ TRRAP DHX9 NFRKB USP7 HERC2 POLK NPAS2 RAD23A MMS22L DDX12P EP400 CREBBP TFDP1 FAN1 SF3B3 ARID2 FMN2 ATF1 NHEJ1 RPA2 TOP2B | 1.97e-05 | 1081 | 201 | 26 | GO:0006259 |
| GeneOntologyBiologicalProcess | rhythmic process | SP1 MYCBP2 GFPT1 DHX9 NFYA USP7 NPAS2 CREB1 CREBBP CREM PASD1 NCOR1 MTOR | 5.57e-05 | 360 | 201 | 13 | GO:0048511 |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 6.20e-05 | 70 | 201 | 6 | GO:0060261 | |
| GeneOntologyBiologicalProcess | DNA recombination | ANKRD31 UBQLN4 POGZ TRRAP NFRKB MMS22L EP400 CREBBP FAN1 ARID2 NHEJ1 RPA2 TOP2B | 6.95e-05 | 368 | 201 | 13 | GO:0006310 |
| GeneOntologyBiologicalProcess | double-strand break repair | UBQLN4 POGZ TRRAP MMS22L EP400 CREBBP FAN1 ARID2 FMN2 NHEJ1 RPA2 TOP2B | 8.49e-05 | 324 | 201 | 12 | GO:0006302 |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 9.15e-05 | 75 | 201 | 6 | GO:0032922 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 9.46e-05 | 146 | 201 | 8 | GO:2000779 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 9.83e-05 | 188 | 201 | 9 | GO:0000724 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 1.06e-04 | 77 | 201 | 6 | GO:2000144 | |
| GeneOntologyBiologicalProcess | recombinational repair | 1.25e-04 | 194 | 201 | 9 | GO:0000725 | |
| GeneOntologyBiologicalProcess | regulation of transcription initiation by RNA polymerase II | 1.41e-04 | 81 | 201 | 6 | GO:0060260 | |
| GeneOntologyBiologicalProcess | iodide transport | 1.42e-04 | 11 | 201 | 3 | GO:0015705 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via homologous recombination | 1.61e-04 | 83 | 201 | 6 | GO:0010569 | |
| GeneOntologyBiologicalProcess | circadian rhythm | 1.68e-04 | 248 | 201 | 10 | GO:0007623 | |
| GeneOntologyBiologicalProcess | transcription preinitiation complex assembly | 1.83e-04 | 85 | 201 | 6 | GO:0070897 | |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 2.22e-04 | 88 | 201 | 6 | GO:0006289 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | UBQLN4 SUPT20HL2 TRRAP DHX9 NFRKB NPAS2 EP400 CREBBP SF3B3 MTOR ARID2 FMN2 SPRED1 RPA2 HERPUD1 TOP2B | 2.66e-04 | 598 | 201 | 16 | GO:0080135 |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription initiation | 2.66e-04 | 91 | 201 | 6 | GO:2000142 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 3.36e-04 | 95 | 201 | 6 | GO:2000781 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NOL6 UBQLN4 GON4L TRRAP ZC3H3 MED24 BPTF PHC3 INTS2 PRPF40B NFRKB NFYA NFYC TAF4B MED12 NPAS2 KPNA3 KPNA4 MMS22L DDX12P GTF2A1L WDR36 POLR1A EP400 MED29 SCAF8 AHCTF1 VPS4B RELA CREB1 CREBBP CREM TFDP1 PHC1 PASD1 NCOR1 GTF2A1 ARNT KMT2D SYNE3 SF3B3 ARID2 ZNF335 ATF1 NHEJ1 RPA2 | 7.41e-14 | 1377 | 202 | 46 | GO:0140513 |
| GeneOntologyCellularComponent | chromatin | SOX5 ANKRD31 SP1 SP2 SP3 SP4 GON4L SUPT20HL2 POGZ KDM5D TRRAP FOXD4L5 DHX9 BPTF FOXD4L4 NFRKB NFYA NFYC NPAS2 MMS22L DDX12P ZBTB33 EP400 BAZ2B AHCTF1 ADNP2 RELA POU6F1 CREB1 CREBBP CREM TFDP1 PHC1 NCOR1 FOXP4 ARNT SF3B3 ARID2 GMEB1 PAWR ATF1 NFAT5 RPA2 TOP2B | 1.48e-11 | 1480 | 202 | 44 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | SOX5 BDP1 SP1 SP3 TRRAP MED24 NFYA NFYC TAF4B NPAS2 GTF2A1L MED29 RELA CREB1 CREBBP CREM TFDP1 PASD1 NCOR1 GTF2A1 ARNT ARID2 ATF1 NFAT5 | 3.81e-09 | 596 | 202 | 24 | GO:0005667 |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | TRRAP MED24 NFYA NFYC TAF4B NPAS2 GTF2A1L MED29 CREB1 CREBBP CREM TFDP1 PASD1 GTF2A1 ARNT ATF1 | 9.99e-09 | 272 | 202 | 16 | GO:0090575 |
| GeneOntologyCellularComponent | ATF4-CREB1 transcription factor complex | 3.53e-06 | 4 | 202 | 3 | GO:1990589 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | PSMA5 UBQLN4 GATB SUPT20HL2 KEAP1 TRRAP DHX9 MED24 PHC3 TAF4B MED12 RAD23A GTF2A1L POLR1A EP400 CREBBP PHC1 GTF2A1 ARNT SF3B3 MTOR UBE3C NHEJ1 | 6.97e-05 | 972 | 202 | 23 | GO:0140535 |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 7.15e-05 | 9 | 202 | 3 | GO:0014731 | |
| GeneOntologyCellularComponent | INO80-type complex | 1.44e-04 | 28 | 202 | 4 | GO:0097346 | |
| GeneOntologyCellularComponent | PML body | 2.16e-04 | 125 | 202 | 7 | GO:0016605 | |
| GeneOntologyCellularComponent | ATPase complex | 2.62e-04 | 129 | 202 | 7 | GO:1904949 | |
| GeneOntologyCellularComponent | peptidase complex | 3.16e-04 | 133 | 202 | 7 | GO:1905368 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 3.40e-04 | 96 | 202 | 6 | GO:0070603 | |
| GeneOntologyCellularComponent | transcription factor TFIIA complex | 9.12e-04 | 5 | 202 | 2 | GO:0005672 | |
| GeneOntologyCellularComponent | CLOCK-BMAL transcription complex | 9.12e-04 | 5 | 202 | 2 | GO:1990513 | |
| GeneOntologyCellularComponent | nuclear body | SP3 GON4L DHX9 PRPF40B NUFIP2 USP7 TOLLIP POLK EP400 AHCTF1 CREBBP PHC1 PASD1 HIPK3 ARNT MTOR RPA2 SDCBP2 SP140 | 1.25e-03 | 903 | 202 | 19 | GO:0016604 |
| GeneOntologyCellularComponent | CCAAT-binding factor complex | 1.36e-03 | 6 | 202 | 2 | GO:0016602 | |
| GeneOntologyCellularComponent | SAGA complex | 1.75e-03 | 25 | 202 | 3 | GO:0000124 | |
| HumanPheno | Thin upper lip vermilion | POGZ QRICH1 TRRAP BPTF GPC4 SYT1 HERC2 MAPRE2 MED12 PUF60 CREBBP PHC1 KMT2D MTOR ARID2 UNC80 | 1.14e-05 | 339 | 71 | 16 | HP:0000219 |
| HumanPheno | Thin lips | POGZ QRICH1 TRRAP BPTF GPC4 SYT1 HERC2 MAPRE2 MED12 PUF60 CREBBP PHC1 KMT2D MTOR ARID2 UNC80 | 1.14e-05 | 339 | 71 | 16 | HP:0000213 |
| MousePheno | anemia | SPTA1 UNC13D POGZ MED24 PROM2 GPC4 ABCG5 ANK1 EP400 CREBBP TG NCOR1 SLC20A1 PTCH2 NFAT5 | 4.59e-06 | 306 | 169 | 15 | MP:0001577 |
| Domain | pKID | 1.19e-06 | 3 | 199 | 3 | PF02173 | |
| Domain | KID | 1.19e-06 | 3 | 199 | 3 | PS50953 | |
| Domain | Coactivator_CBP_pKID | 1.19e-06 | 3 | 199 | 3 | IPR003102 | |
| Domain | Sp1_fam | 2.50e-06 | 10 | 199 | 4 | IPR030450 | |
| Domain | Leuzip_CREB | 4.73e-06 | 4 | 199 | 3 | IPR001630 | |
| Domain | FAT | 2.33e-05 | 6 | 199 | 3 | PS51189 | |
| Domain | FATC | 2.33e-05 | 6 | 199 | 3 | PS51190 | |
| Domain | FATC_dom | 2.33e-05 | 6 | 199 | 3 | IPR003152 | |
| Domain | PIK_FAT | 2.33e-05 | 6 | 199 | 3 | IPR014009 | |
| Domain | FATC | 2.33e-05 | 6 | 199 | 3 | SM01343 | |
| Domain | TFIIA_asu_N | 1.13e-04 | 2 | 199 | 2 | IPR013028 | |
| Domain | TFIIA_asu/bsu | 1.13e-04 | 2 | 199 | 2 | IPR004855 | |
| Domain | TFIIA | 1.13e-04 | 2 | 199 | 2 | SM01371 | |
| Domain | TFIIA | 1.13e-04 | 2 | 199 | 2 | PF03153 | |
| Domain | - | 1.13e-04 | 2 | 199 | 2 | 1.10.287.100 | |
| Domain | Znf_FYVE_PHD | 1.82e-04 | 147 | 199 | 8 | IPR011011 | |
| Domain | - | 3.36e-04 | 3 | 199 | 2 | 2.30.18.10 | |
| Domain | TFIIA_b-brl | 3.36e-04 | 3 | 199 | 2 | IPR009088 | |
| Domain | - | 6.02e-04 | 16 | 199 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 6.02e-04 | 16 | 199 | 3 | SM00146 | |
| Domain | BROMODOMAIN_1 | 6.27e-04 | 37 | 199 | 4 | PS00633 | |
| Domain | DDT | 6.68e-04 | 4 | 199 | 2 | PF02791 | |
| Domain | TFIIA_a-hlx | 6.68e-04 | 4 | 199 | 2 | IPR009083 | |
| Domain | Bromodomain | 6.95e-04 | 38 | 199 | 4 | PF00439 | |
| Domain | MYB_LIKE | 6.95e-04 | 38 | 199 | 4 | PS50090 | |
| Domain | PI3_PI4_kinase | 8.64e-04 | 18 | 199 | 3 | PF00454 | |
| Domain | ZF_ZZ_2 | 8.64e-04 | 18 | 199 | 3 | PS50135 | |
| Domain | PI3_4_KINASE_1 | 8.64e-04 | 18 | 199 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 8.64e-04 | 18 | 199 | 3 | PS00916 | |
| Domain | ZF_ZZ_1 | 8.64e-04 | 18 | 199 | 3 | PS01357 | |
| Domain | PI3/4_kinase_cat_dom | 8.64e-04 | 18 | 199 | 3 | IPR000403 | |
| Domain | ZZ | 8.64e-04 | 18 | 199 | 3 | PF00569 | |
| Domain | PI3_4_KINASE_3 | 8.64e-04 | 18 | 199 | 3 | PS50290 | |
| Domain | BROMODOMAIN_2 | 9.30e-04 | 41 | 199 | 4 | PS50014 | |
| Domain | Znf_ZZ | 1.02e-03 | 19 | 199 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 1.02e-03 | 19 | 199 | 3 | SM00291 | |
| Domain | Bromodomain | 1.02e-03 | 42 | 199 | 4 | IPR001487 | |
| Domain | BROMO | 1.02e-03 | 42 | 199 | 4 | SM00297 | |
| Domain | - | 1.02e-03 | 42 | 199 | 4 | 1.20.920.10 | |
| Domain | DDT | 1.11e-03 | 5 | 199 | 2 | SM00571 | |
| Domain | Znf_FCS | 1.11e-03 | 5 | 199 | 2 | IPR012313 | |
| Domain | ZnF_Rad18 | 1.11e-03 | 5 | 199 | 2 | SM00734 | |
| Domain | DDT_dom | 1.11e-03 | 5 | 199 | 2 | IPR018501 | |
| Domain | WHIM2_dom | 1.11e-03 | 5 | 199 | 2 | IPR028941 | |
| Domain | WSD | 1.11e-03 | 5 | 199 | 2 | PF15613 | |
| Domain | FATC | 1.11e-03 | 5 | 199 | 2 | PF02260 | |
| Domain | Znf_Rad18_put | 1.11e-03 | 5 | 199 | 2 | IPR006642 | |
| Domain | PHD | 1.23e-03 | 75 | 199 | 5 | PF00628 | |
| Domain | Znf_PHD-finger | 1.55e-03 | 79 | 199 | 5 | IPR019787 | |
| Domain | DDT | 1.65e-03 | 6 | 199 | 2 | PS50827 | |
| Domain | ZF_FCS | 1.65e-03 | 6 | 199 | 2 | PS51024 | |
| Domain | Myb-like_dom | 1.65e-03 | 6 | 199 | 2 | IPR017877 | |
| Domain | FAT | 1.65e-03 | 6 | 199 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.65e-03 | 6 | 199 | 2 | IPR003151 | |
| Domain | Spectrin | 1.80e-03 | 23 | 199 | 3 | PF00435 | |
| Domain | SANT | 1.96e-03 | 50 | 199 | 4 | SM00717 | |
| Domain | SANT/Myb | 2.27e-03 | 52 | 199 | 4 | IPR001005 | |
| Domain | Arm_3 | 2.29e-03 | 7 | 199 | 2 | PF16186 | |
| Domain | APC_su10/DOC_dom | 2.29e-03 | 7 | 199 | 2 | IPR004939 | |
| Domain | Importing_su_alpha | 2.29e-03 | 7 | 199 | 2 | IPR024931 | |
| Domain | IBB | 2.29e-03 | 7 | 199 | 2 | PF01749 | |
| Domain | DOC | 2.29e-03 | 7 | 199 | 2 | PS51284 | |
| Domain | ANAPC10 | 2.29e-03 | 7 | 199 | 2 | PF03256 | |
| Domain | Arm_3 | 2.29e-03 | 7 | 199 | 2 | IPR032413 | |
| Domain | APC10 | 2.29e-03 | 7 | 199 | 2 | SM01337 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | SP1 ACOX1 PLIN2 MED24 NFYA NFYC MED12 NPAS2 MED29 CREBBP NCOR1 ARNT HELZ2 | 3.84e-10 | 118 | 151 | 13 | M27316 |
| Pathway | BIOCARTA_TERC_PATHWAY | 1.87e-07 | 6 | 151 | 4 | M22047 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 1.87e-07 | 6 | 151 | 4 | MM1564 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | SP1 RPS5 PSMA5 HSPH1 KEAP1 GFPT1 PHC3 NFYA NFYC NPAS2 EP400 RELA CREB1 CREBBP TFDP1 PHC1 NCOR1 ARNT MTOR HELZ2 RPA2 RPL3 HERPUD1 TUBAL3 | 7.56e-06 | 828 | 151 | 24 | M27827 |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | SP1 SP3 SALL3 DHX9 USP7 MED12 EP400 RELA CREB1 CREBBP PHC1 KMT2D MTOR | 2.12e-05 | 301 | 151 | 13 | MM15983 |
| Pathway | BIOCARTA_HCMV_PATHWAY | 2.70e-05 | 17 | 151 | 4 | M8353 | |
| Pathway | BIOCARTA_HCMV_PATHWAY | 2.70e-05 | 17 | 151 | 4 | MM1408 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 3.20e-05 | 84 | 151 | 7 | M1008 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 8.15e-05 | 42 | 151 | 5 | M27172 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.02e-04 | 70 | 151 | 6 | M938 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 1.29e-04 | 73 | 151 | 6 | M39401 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.72e-04 | 49 | 151 | 5 | M41832 | |
| Pathway | REACTOME_ADIPOGENESIS | 1.78e-04 | 110 | 151 | 7 | M48259 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 2.29e-04 | 52 | 151 | 5 | M2404 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 2.45e-04 | 82 | 151 | 6 | M2 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 2.98e-04 | 55 | 151 | 5 | M27001 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX5 ZNF384 SP1 SP2 SP3 SP4 ZNF274 GON4L TSC22D2 ZNF236 ZC3H3 FOXD4L4 NFYA NFYC NPAS2 ZBTB33 AHCTF1 ADNP2 RELA POU6F1 CREB1 CREM TFDP1 PKNOX2 FOXP4 ARNT KMT2D USF3 ZNF335 GMEB1 ZNF76 ATF1 NFAT5 | 6.63e-17 | 908 | 205 | 33 | 19274049 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | PSMA5 POGZ QRICH1 RRBP1 TRRAP BPTF PRRC2C NFYA NFYC ANKRD52 ZBTB33 EP400 PUF60 AGGF1 RELA CPS1 KANK2 CREB1 CREBBP CREM TFDP1 NCOR1 FOXP4 ARNT KMT2D EIF5B ATF1 NHEJ1 PUM1 RPA2 TOP2B | 7.23e-16 | 857 | 205 | 31 | 25609649 |
| Pubmed | SOX5 SMG1 SP1 SP2 RPS5 PSMA5 HSPH1 GON4L POGZ TRRAP MED24 BPTF PHC3 PRRC2C NFRKB NFYA USP7 NFYC HERC2 ZBTB33 EP400 SCAF8 MRPL28 RELA CREB1 CREBBP TFDP1 NCOR1 FOXP4 IGF2BP2 ARNT KMT2D ARID2 GMEB1 ATF1 LSM14B PUM1 RPA2 ZC3HAV1 | 1.04e-15 | 1429 | 205 | 39 | 35140242 | |
| Pubmed | SOX5 SP1 SP2 SP3 SP4 SALL3 ZNF274 POGZ KDM5D ZNF236 BPTF NFYA NFYC NPAS2 ANKFY1 ZBTB33 AHCTF1 RELA CREM TFDP1 PHC1 NCOR1 GTF2A1 ARNT ARID2 GMEB1 ZNF76 ATF1 NFAT5 ZC3HAV1 | 1.11e-15 | 808 | 205 | 30 | 20412781 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF384 SALL3 RPS5 NOL6 POGZ RRBP1 DHX9 BPTF PHC3 PRRC2C NUFIP2 NFRKB SYT1 KPNA3 ZBTB33 WDR36 EP400 BAZ2B PUF60 AHCTF1 CREB1 CREM NCOR1 PAXBP1 SF3B3 ARID2 EIF5B ATF1 PUM1 TOP2B | 8.53e-14 | 954 | 205 | 30 | 36373674 |
| Pubmed | ZNF384 SP4 MYCBP2 PSMA5 HSPH1 POGZ QRICH1 TRRAP MED24 BPTF PRRC2C NFRKB MED12 RAD23A EP400 MED29 BAZ2B PUF60 CREB1 CREBBP NCOR1 IGF2BP2 ARNT KMT2D LMAN1 ARID2 GMEB1 EIF5B ATF1 LSM14B RPA2 TOP2B | 1.04e-13 | 1103 | 205 | 32 | 34189442 | |
| Pubmed | SP1 POGZ NFYA NFYC NAV2 TOLLIP HERC2 GOLGB1 KPNA4 ANK3 COBLL1 ADNP2 RELA CREB1 CREBBP HIPK3 GTF2A1 USF3 ARID2 CEP250 MAP2K5 HERPUD1 | 1.86e-13 | 486 | 205 | 22 | 20936779 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | SOX5 SP2 GON4L POGZ DHX9 PHC3 NFRKB GPC4 USP7 NFYC KPNA3 KPNA4 EP400 ADNP2 CREBBP FOXP4 KMT2D ARID2 RPA2 RPL3 | 3.62e-13 | 398 | 205 | 20 | 35016035 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ZNF384 MYCBP2 RPS5 PSMA5 HSPH1 NOL6 POGZ RRBP1 TRRAP GFPT1 DHX9 USP7 HERC2 MAPRE2 ANKRD52 MED12 GOLGA4 KPNA3 FNDC3B ANKFY1 WDR36 POLR1A EP400 AHCTF1 KIF21A ADNP2 CREBBP IGF2BP2 SF3B3 EIF5B PUM1 RPL3 TOP2B ZC3HAV1 | 9.26e-13 | 1353 | 205 | 34 | 29467282 |
| Pubmed | MYCBP2 RPS5 NOL6 POGZ TRRAP GFPT1 BPTF PRRC2C NUFIP2 USP7 HERC2 ANKRD52 MED12 WDR36 POLR1A PUF60 AHCTF1 IGF2BP2 MTOR HELZ2 EIF5B PUM1 RPL3 ZC3HAV1 | 1.22e-12 | 653 | 205 | 24 | 22586326 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SMG1 GPBP1 MYCBP2 RPS5 NOL6 FYCO1 RRBP1 TRRAP GFPT1 DHX9 NUFIP2 HERC2 WDR36 POLR1A EP400 ARID2 RPA2 RPL3 TOP2B ZC3HAV1 | 2.28e-12 | 440 | 205 | 20 | 34244565 |
| Pubmed | SOX5 SMG1 CNKSR1 MYCBP2 UBQLN4 QRICH1 KEAP1 RRBP1 HERC2 GOLGB1 ANK3 CREBBP HIPK3 NCOR1 ARNT KMT2D CEP250 GMEB1 SPRED1 ZNF76 PUM1 KIF13A | 8.78e-12 | 591 | 205 | 22 | 15231748 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SP1 SP3 SP4 KEAP1 TSC22D2 KDM5D MAP3K1 PHC3 USP7 ADGRL3 KPNA3 KPNA4 ANK3 EP400 PKNOX2 NCOR1 USF3 ARID2 SDCBP2 | 1.35e-11 | 430 | 205 | 19 | 35044719 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP1 SP2 RPS5 SPTA1 UBQLN4 POGZ RRBP1 TRRAP DHX9 BPTF PHC3 INTS2 NFRKB USP7 WDR36 EP400 MED29 BAZ2B AHCTF1 CREB1 CREM NCOR1 ARNT KMT2D PAXBP1 SF3B3 ATF1 RPA2 RPL3 TOP2B ZC3HAV1 | 3.49e-11 | 1294 | 205 | 31 | 30804502 |
| Pubmed | SOX5 SP1 SP2 SP3 ZNF274 POGZ QRICH1 FOXD4L5 FOXD4L4 ANKFY1 ZBTB33 AGGF1 POU6F1 CREBBP CREM TFDP1 PHC1 PKNOX2 GTF2A1 FOXP4 ARNT GMEB1 NFAT5 | 4.51e-11 | 709 | 205 | 23 | 22988430 | |
| Pubmed | SP3 HSPH1 NOL6 GON4L TRRAP MED24 PHC3 INTS2 GLG1 NUFIP2 NFRKB USP7 TOLLIP HERC2 MED12 GOLGB1 KPNA3 KPNA4 FNDC3B WDR36 POLR1A EP400 SCAF8 AHCTF1 RELA KANK2 PAXBP1 ARID2 HELZ2 EIF5B ATF1 LSM14B ZC3HAV1 | 6.65e-11 | 1497 | 205 | 33 | 31527615 | |
| Pubmed | MYCBP2 POGZ KEAP1 TRRAP BPTF PRRC2C NUFIP2 NFRKB USP7 MED12 ZBTB33 ANK3 EP400 PUF60 AHCTF1 CREBBP NCOR1 KMT2D ARID2 ZC3HAV1 | 1.19e-10 | 549 | 205 | 20 | 38280479 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SP1 MYCBP2 PSMA5 POGZ RRBP1 TRRAP DHX9 MED24 BPTF PHC3 NFRKB USP7 GOLGA4 EP400 SCAF8 NCOR1 KMT2D PAXBP1 ZNF335 HELZ2 EIF5B TOP2B ZC3HAV1 | 2.51e-10 | 774 | 205 | 23 | 15302935 |
| Pubmed | RPS5 PSMA5 HSPH1 RRBP1 GFPT1 DHX9 NUFIP2 USP7 TOLLIP MED12 KPNA3 KPNA4 PUF60 VPS4B KIF21A DNAH1 NCOR1 IGF2BP2 ARNT PAXBP1 SF3B3 AKAP9 EIF5B PAWR NFAT5 RPA2 RPL3 ZC3HAV1 TJP3 | 3.20e-10 | 1247 | 205 | 29 | 27684187 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | SALL3 UBQLN4 POGZ TRRAP MED24 BPTF MED12 EP400 MED29 PHC1 FOXP4 KMT2D | 3.75e-10 | 167 | 205 | 12 | 20362541 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SP2 RPS5 HSPH1 NOL6 KEAP1 RRBP1 DHX9 NFRKB MAPRE2 WDR36 POLR1A ANK1 EP400 PUF60 SCAF8 AHCTF1 NCOR1 IGF2BP2 PAXBP1 SF3B3 LMAN1 EIF5B ATF1 PUM1 RPA2 RPL3 TOP2B TUBAL3 ZC3HAV1 | 1.13e-09 | 1318 | 205 | 29 | 30463901 |
| Pubmed | 1.17e-09 | 4 | 205 | 4 | 27889927 | ||
| Pubmed | RPS5 PSMA5 NOL6 TRRAP DHX9 NUFIP2 WDR36 POLR1A PUF60 AHCTF1 MRPL28 CPS1 KANK2 NCOR1 IGF2BP2 PAXBP1 SF3B3 ARID2 PUM1 NFAT5 RPL3 TOP2B ZC3HAV1 | 1.42e-09 | 847 | 205 | 23 | 35850772 | |
| Pubmed | GON4L DHX9 FAM186A USP7 GOLGB1 COBLL1 KMT2D SF3B3 ZNF335 CEP250 KIF13A TOP2B ZC3HAV1 | 1.63e-09 | 234 | 205 | 13 | 36243803 | |
| Pubmed | RPS5 HSPH1 KEAP1 RRBP1 GFPT1 DHX9 PRRC2C NUFIP2 MAPRE2 MED12 GOLGA4 GOLGB1 ZBTB33 ANK3 AHCTF1 COBLL1 SF3B3 LMAN1 EIF5B RPL3 ZC3HAV1 | 1.64e-09 | 708 | 205 | 21 | 39231216 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ZNF384 SP1 SP2 ZNF274 KDM5D ZNF236 NFYA NPAS2 ZBTB33 GTF2A1L POLR1A RELA POU6F1 CREB1 CREBBP TFDP1 PKNOX2 GTF2A1 ARNT CARF GMEB1 EIF5B PAWR | 2.73e-09 | 877 | 205 | 23 | 20211142 |
| Pubmed | POGZ KEAP1 TRRAP ZC3H3 BPTF PRPF40B NFRKB USP7 TAF4B ANKRD52 KPNA3 ZBTB33 EP400 AHCTF1 ADNP2 KANK2 CREBBP TFDP1 ARHGAP4 FOXP4 IGF2BP2 SF3B3 ARID2 FMN2 UNC80 SP140 | 2.77e-09 | 1116 | 205 | 26 | 31753913 | |
| Pubmed | MYCBP2 UBQLN4 POGZ KEAP1 PHC3 ANKRD52 MED12 GOLGB1 ANKFY1 ZBTB33 VPS4B TFDP1 PHC1 NCOR1 KMT2D LMAN1 | 4.60e-09 | 418 | 205 | 16 | 34709266 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MYCBP2 RPS5 NOL6 KEAP1 RRBP1 TRRAP MAP3K1 DHX9 BPTF PRRC2C NUFIP2 HERC2 MED12 WDR36 POLR1A AGGF1 IGF2BP2 ARID2 UBE3C TOP2B ZC3HAV1 | 5.54e-09 | 759 | 205 | 21 | 35915203 |
| Pubmed | 5.83e-09 | 5 | 205 | 4 | 20538607 | ||
| Pubmed | 5.83e-09 | 5 | 205 | 4 | 10547281 | ||
| Pubmed | SALL3 HSPH1 UNC13D MED24 PHC3 INTS2 GLG1 NFRKB GPC4 NFYC TOLLIP SYT1 ANKRD12 POLK GOLGB1 KPNA3 ANK3 AHCTF1 PAXBP1 SLC20A1 FMN2 SPRED1 PUM1 KIF13A NFAT5 | 7.02e-09 | 1084 | 205 | 25 | 11544199 | |
| Pubmed | PSMA5 QRICH1 RRBP1 TRRAP GFPT1 DHX9 MED24 BPTF USP7 MED12 RAD23A WDR36 POLR1A EP400 MED29 PUF60 CREBBP NCOR1 SF3B3 EIF5B ATF1 NHEJ1 RPA2 TOP2B | 8.79e-09 | 1014 | 205 | 24 | 32416067 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZNF384 HSPH1 KEAP1 RRBP1 GFPT1 PHC3 PRRC2C NUFIP2 USP7 MAPRE2 GOLGB1 ZBTB33 WDR36 EP400 PUF60 AHCTF1 GTF2A1 IGF2BP2 ARID2 EIF5B RPL3 TOP2B ZC3HAV1 | 8.85e-09 | 934 | 205 | 23 | 33916271 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | NOL6 POGZ RRBP1 BPTF ZBTB33 WDR36 EP400 PUF60 AHCTF1 SF3B3 RPL3 TOP2B TUBAL3 | 9.53e-09 | 271 | 205 | 13 | 32433965 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SP2 QRICH1 NUFIP2 NFRKB USP7 POLK CEP97 ZBTB33 EP400 CPS1 CREBBP NCOR1 ARNT LSM14B TOP2B ZC3HAV1 | 1.07e-08 | 444 | 205 | 16 | 34795231 |
| Pubmed | 1.70e-08 | 76 | 205 | 8 | 27542412 | ||
| Pubmed | 1.74e-08 | 6 | 205 | 4 | 16201967 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | NOL6 POGZ TRRAP MED24 BPTF PHC3 NFRKB HERC2 KPNA3 WDR36 MED29 MRPL28 TFDP1 PHC1 EIF5B RPL3 TOP2B | 2.21e-08 | 533 | 205 | 17 | 30554943 |
| Pubmed | NOL6 TRRAP BPTF INTS2 PRRC2C USP7 CEP97 KPNA3 KPNA4 WDR36 EP400 AHCTF1 KMT2D PAXBP1 LSM14B TOP2B | 2.30e-08 | 469 | 205 | 16 | 27634302 | |
| Pubmed | 2.73e-08 | 53 | 205 | 7 | 35216969 | ||
| Pubmed | 3.58e-08 | 157 | 205 | 10 | 30186101 | ||
| Pubmed | 4.05e-08 | 7 | 205 | 4 | 15817708 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZNF384 MYCBP2 FYCO1 PLXND1 ZNF236 TRRAP PROM2 USP7 NAV2 HERC2 MED12 EP400 PUF60 LAMB3 NCOR1 KMT2D LLGL2 SYNE3 MTOR ZNF335 HELZ2 UBE3C PUM1 TJP3 | 4.44e-08 | 1105 | 205 | 24 | 35748872 |
| Pubmed | HSPH1 KEAP1 RRBP1 DHX9 USP7 NAV2 RAD23A KPNA3 KPNA4 ANK3 LAMB3 TFDP1 ARID2 UBE3C RPA2 RPL3 TOP2B ZC3HAV1 | 4.90e-08 | 634 | 205 | 18 | 34591612 | |
| Pubmed | SP1 CNKSR1 PSMA5 HSPH1 RRBP1 GFPT1 NUFIP2 NAV2 ANKRD52 AHCTF1 COBLL1 NCOR1 GMEB1 EIF5B KIF13A ZC3HAV1 | 6.03e-08 | 503 | 205 | 16 | 16964243 | |
| Pubmed | MYCBP2 HSPH1 GATB RRBP1 DHX9 GLG1 HERC2 ANKRD52 GOLGA4 GOLGB1 RAD23A WDR36 ANK3 AHCTF1 MRPL28 KANK2 TFDP1 GTF2A1 PAXBP1 SYNE3 SF3B3 LMAN1 AKAP9 SLC20A1 EIF5B RPL3 TOP2B ZC3HAV1 | 6.24e-08 | 1487 | 205 | 28 | 33957083 | |
| Pubmed | MED24 NFRKB USP7 MED12 ZBTB33 EP400 CREB1 CREBBP NCOR1 FOXP4 KMT2D PAXBP1 | 7.61e-08 | 268 | 205 | 12 | 33640491 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | ZNF384 RPS5 HSPH1 NOL6 POGZ DHX9 USP7 KPNA3 KPNA4 ZBTB33 EP400 CREB1 TFDP1 ARNT SF3B3 ATF1 NFAT5 | 8.01e-08 | 583 | 205 | 17 | 29844126 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | TRRAP DHX9 USP7 MED12 PUF60 NCOR1 ARNT KMT2D SF3B3 ARID2 TOP2B | 8.85e-08 | 220 | 205 | 11 | 35785414 |
| Pubmed | SP1 SP3 RPS5 HSPH1 UNC13D QRICH1 KEAP1 TSC22D2 ZNF236 TRRAP GFPT1 MED24 INTS2 NFRKB USP7 MED12 KPNA3 KPNA4 CREB1 CREM TFDP1 ARNT LLGL2 SF3B3 SLC20A1 ARID2 | 8.97e-08 | 1327 | 205 | 26 | 32694731 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | RRBP1 PHC3 PRRC2C NUFIP2 CEP97 SCAF8 IGF2BP2 AKAP9 PAWR ATF1 LSM14B RPA2 ZC3HAV1 | 9.28e-08 | 329 | 205 | 13 | 34316702 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPS5 PSMA5 HSPH1 NOL6 POGZ RRBP1 GFPT1 DHX9 USP7 GOLGA4 NPAS2 ANKFY1 WDR36 POLR1A PUF60 PAXBP1 SF3B3 LMAN1 CLCA2 MTOR EIF5B UBE3C PUM1 RPA2 RPL3 TOP2B ZC3HAV1 | 9.72e-08 | 1425 | 205 | 27 | 30948266 |
| Pubmed | RPS5 PSMA5 POGZ GFPT1 DHX9 KPNA3 POLR1A PUF60 LAMB3 KANK2 IGF2BP2 SF3B3 EIF5B LSM14B PUM1 RPL3 TOP2B | 1.23e-07 | 601 | 205 | 17 | 33658012 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | ZNF384 NOL6 POGZ TRRAP MED24 BPTF NUFIP2 MED12 EP400 NCOR1 KMT2D EIF5B TOP2B | 1.40e-07 | 341 | 205 | 13 | 32971831 |
| Pubmed | GON4L POGZ SNX13 PRRC2C NUFIP2 ANKRD12 ADGRL3 ANKFY1 EP400 SCAF8 AKAP9 UBE3C PUM1 NFAT5 | 1.61e-07 | 407 | 205 | 14 | 12693553 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | SMG1 ZNF384 SP1 RPS5 QRICH1 TRRAP MED24 MED12 KPNA4 WDR36 EP400 LAMB3 KMT2D PAXBP1 | 1.76e-07 | 410 | 205 | 14 | 26949251 |
| Pubmed | Interaction network of human early embryonic transcription factors. | SOX5 POGZ BPTF NFRKB MED12 EP400 CREBBP TFDP1 NCOR1 FOXP4 ARNT KMT2D ARID2 | 1.95e-07 | 351 | 205 | 13 | 38297188 |
| Pubmed | 2.02e-07 | 3 | 205 | 3 | 15297147 | ||
| Pubmed | 2.02e-07 | 3 | 205 | 3 | 22386572 | ||
| Pubmed | Curcumin decreases specificity protein expression in bladder cancer cells. | 2.02e-07 | 3 | 205 | 3 | 18593936 | |
| Pubmed | 2.02e-07 | 3 | 205 | 3 | 10722738 | ||
| Pubmed | 2.02e-07 | 3 | 205 | 3 | 21919647 | ||
| Pubmed | 2.02e-07 | 3 | 205 | 3 | 25793500 | ||
| Pubmed | 2.02e-07 | 3 | 205 | 3 | 36759621 | ||
| Pubmed | 2.02e-07 | 3 | 205 | 3 | 22198373 | ||
| Pubmed | Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene. | 2.02e-07 | 3 | 205 | 3 | 11532028 | |
| Pubmed | Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3. | 2.02e-07 | 3 | 205 | 3 | 7559627 | |
| Pubmed | 2.02e-07 | 3 | 205 | 3 | 23540600 | ||
| Pubmed | 2.02e-07 | 3 | 205 | 3 | 26967243 | ||
| Pubmed | 2.02e-07 | 3 | 205 | 3 | 20413592 | ||
| Pubmed | 2.02e-07 | 3 | 205 | 3 | 26431879 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYCBP2 RPS5 PSMA5 NOL6 RRBP1 TRRAP DHX9 BPTF HERC2 GOLGB1 WDR36 POLR1A EP400 PUF60 IGF2BP2 SF3B3 SLC20A1 EIF5B PAWR PUM1 RPL3 TOP2B | 2.03e-07 | 1024 | 205 | 22 | 24711643 |
| Pubmed | Composite co-activator ARC mediates chromatin-directed transcriptional activation. | 2.09e-07 | 23 | 205 | 5 | 10235267 | |
| Pubmed | MYCBP2 RPS5 HSPH1 KEAP1 RRBP1 TRRAP GFPT1 DHX9 BPTF GLG1 PRRC2C NUFIP2 TOLLIP KPNA3 KPNA4 KIF21A KANK2 NCOR1 LMAN1 EIF5B PAWR UBE3C RPA2 RPL3 ZC3HAV1 | 2.20e-07 | 1297 | 205 | 25 | 33545068 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.32e-07 | 146 | 205 | 9 | 23892456 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 CPAMD8 CDH26 MYCBP2 RRBP1 ZNF236 TRRAP BPTF INTS2 PROM2 ANKRD12 POLK GOLGA4 GOLGB1 NPAS2 POLR1A ANK3 SCAF8 CREBBP DNAH1 HIPK3 PKNOX2 FOXP4 USF3 UBE3C NFAT5 ZC3HAV1 | 2.32e-07 | 1489 | 205 | 27 | 28611215 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | ZNF274 SUPT20HL2 GFPT1 DHX9 BPTF GPC4 RPS6KA6 TAF4B POLK MMS22L ZNF335 EIF5B PUM1 | 2.86e-07 | 363 | 205 | 13 | 14691545 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 TOPAZ1 HSPH1 RRBP1 TRRAP USP7 NAV2 MED12 KPNA4 POLR1A ANK1 ANK3 ARID2 PUM1 NACA4P | 3.09e-07 | 497 | 205 | 15 | 36774506 |
| Pubmed | BDP1 SP2 TRRAP DHX9 BPTF HERC2 ZBTB33 POLR1A FAN1 HELZ2 EIF5B | 3.20e-07 | 250 | 205 | 11 | 33536335 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPS5 HSPH1 NOL6 KEAP1 RRBP1 GFPT1 ITIH2 DHX9 PRRC2C NUFIP2 USP7 WDR36 PUF60 AHCTF1 LAMB3 MRPL28 IGF2BP2 SF3B3 HELZ2 EIF5B PAWR LSM14B RPL3 ZC3HAV1 | 4.64e-07 | 1257 | 205 | 24 | 36526897 |
| Pubmed | 4.78e-07 | 159 | 205 | 9 | 30581152 | ||
| Pubmed | HSPH1 NOL6 POGZ KEAP1 RRBP1 GFPT1 ITIH2 MAP3K1 PHC3 PRRC2C NUFIP2 HERC2 KPNA3 WDR36 EP400 PUF60 AHCTF1 COBLL1 CPM IGF2BP2 PAXBP1 AKAP9 HELZ2 PAWR LSM14B | 6.11e-07 | 1371 | 205 | 25 | 36244648 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYCBP2 NOL6 FYCO1 KEAP1 INTS2 USP7 TOLLIP HERC2 GOLGB1 KPNA3 KPNA4 WDR36 KANK2 LMAN1 AKAP9 MTOR CEP250 UBE3C | 6.22e-07 | 754 | 205 | 18 | 33060197 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF384 POGZ TRRAP BPTF PHC3 NFRKB USP7 HERC2 RAD23A BAZ2B AHCTF1 ADNP2 TFDP1 PHC1 ARID2 TOP2B | 7.61e-07 | 608 | 205 | 16 | 36089195 |
| Pubmed | 8.04e-07 | 4 | 205 | 3 | 11354513 | ||
| Pubmed | 8.04e-07 | 4 | 205 | 3 | 21262356 | ||
| Pubmed | 8.04e-07 | 4 | 205 | 3 | 14970236 | ||
| Pubmed | 8.04e-07 | 4 | 205 | 3 | 28009602 | ||
| Pubmed | 8.04e-07 | 4 | 205 | 3 | 15781457 | ||
| Pubmed | 8.04e-07 | 4 | 205 | 3 | 16007092 | ||
| Pubmed | Ca2+-dependent block of CREB-CBP transcription by repressor DREAM. | 8.04e-07 | 4 | 205 | 3 | 12198160 | |
| Pubmed | CREB binding protein is required for both short-term and long-term memory formation. | 8.04e-07 | 4 | 205 | 3 | 20881124 | |
| Pubmed | 8.04e-07 | 4 | 205 | 3 | 15788387 | ||
| Pubmed | NOL6 BPTF USP7 MAPRE2 CEP97 MED12 GOLGA4 WDR36 EP400 RELA KANK2 GTF2A1 ARID2 LSM14B | 9.49e-07 | 472 | 205 | 14 | 38943005 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | ZNF384 SP1 SP2 SP3 ZNF274 NPAS2 ZBTB33 POU6F1 CREB1 CREM PKNOX2 GMEB1 ZNF76 NFAT5 ZSCAN23 | 9.58e-07 | 544 | 205 | 15 | 28473536 |
| Pubmed | ACOX1 NOL6 POGZ DHX9 BAZ2B AHCTF1 CPM SYNE3 SF3B3 CEP250 RPL3 TOP2B | 9.65e-07 | 340 | 205 | 12 | 29478914 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPS5 HSPH1 NOL6 RRBP1 GFPT1 DHX9 NUFIP2 USP7 WDR36 POLR1A PUF60 AHCTF1 CPS1 LLGL2 SF3B3 EIF5B PAWR RPL3 TUBAL3 ZC3HAV1 | 1.01e-06 | 949 | 205 | 20 | 36574265 |
| Pubmed | ZNF384 SP2 PHC3 INTS2 GPC4 USP7 KPNA4 EP400 BAZ2B NCOR1 FOXP4 | 1.05e-06 | 282 | 205 | 11 | 23667531 | |
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 1.19e-06 | 91 | 205 | 7 | 20362542 | |
| Interaction | SRF interactions | SP1 SP2 POGZ BPTF PHC3 GPC4 NFYA NFYC ADNP2 RELA CREB1 CREBBP FOXP4 ARID2 RPA2 | 1.01e-11 | 139 | 202 | 15 | int:SRF |
| Interaction | FHL2 interactions | SP1 SP2 SP3 SP4 POGZ QRICH1 PHC3 ODAM PRRC2C NUFIP2 NFYC TOLLIP NPAS2 EP400 PUF60 KANK2 CREB1 CREBBP PKNOX2 NCOR1 ZNF76 ATF1 NFAT5 | 1.32e-11 | 396 | 202 | 23 | int:FHL2 |
| Interaction | CRX interactions | SOX5 SP1 SP3 SP4 POGZ QRICH1 NFRKB NFYC MED12 NPAS2 EP400 KANK2 CREBBP FOXP4 ARNT KMT2D ARID2 | 8.20e-10 | 254 | 202 | 17 | int:CRX |
| Interaction | SNRNP40 interactions | ZNF384 NOL6 GON4L POGZ QRICH1 KEAP1 PHC3 PRPF40B NFRKB MED12 KPNA3 WDR36 EP400 BAZ2B SCAF8 AHCTF1 ADNP2 AGGF1 TFDP1 NCOR1 ARNT PAXBP1 ARID2 RPA2 RPL3 TOP2B | 1.30e-09 | 637 | 202 | 26 | int:SNRNP40 |
| Interaction | HDAC1 interactions | SP1 SP3 MYCBP2 PSMA5 HSPH1 UBQLN4 GON4L KEAP1 BPTF NFYA USP7 NFYC MED12 GOLGA4 GOLGB1 KPNA3 KPNA4 ANKFY1 ZBTB33 EP400 VPS4B RELA CREB1 CREBBP CREM TFDP1 NCOR1 ARNT KMT2D LMAN1 AKAP9 CEP250 ZNF76 RPA2 TOP2B | 1.37e-09 | 1108 | 202 | 35 | int:HDAC1 |
| Interaction | SIRT6 interactions | SMG1 GPBP1 MYCBP2 RPS5 NOL6 FYCO1 QRICH1 RRBP1 TRRAP GFPT1 DHX9 NUFIP2 USP7 HERC2 MED12 WDR36 POLR1A EP400 RELA CREBBP ARID2 RPA2 RPL3 TOP2B ZC3HAV1 | 4.58e-09 | 628 | 202 | 25 | int:SIRT6 |
| Interaction | KLF15 interactions | SP2 RPS5 PSMA5 POGZ SNX13 PRRC2C NFRKB NFYC EP400 MRPL28 CREBBP NCOR1 FOXP4 KMT2D ARID2 GMEB1 ZNF76 | 6.11e-09 | 290 | 202 | 17 | int:KLF15 |
| Interaction | FEV interactions | SOX5 SP2 POGZ PHC3 NFRKB EP400 CREB1 CREBBP NCOR1 FOXP4 ARNT KMT2D ARID2 ATF1 | 1.83e-08 | 203 | 202 | 14 | int:FEV |
| Interaction | SMC5 interactions | ZNF384 SALL3 RPS5 NOL6 POGZ RRBP1 DHX9 BPTF PHC3 PRRC2C NUFIP2 NFRKB SYT1 KPNA3 ZBTB33 WDR36 EP400 BAZ2B PUF60 AHCTF1 CREB1 CREM NCOR1 PAXBP1 SF3B3 ARID2 EIF5B ATF1 PUM1 RPA2 TOP2B | 2.10e-08 | 1000 | 202 | 31 | int:SMC5 |
| Interaction | CEBPA interactions | ZNF384 SP4 MYCBP2 PSMA5 HSPH1 NOL6 POGZ QRICH1 TRRAP MED24 BPTF PRRC2C NFRKB NFYA MED12 RAD23A EP400 MED29 BAZ2B PUF60 CREB1 CREBBP NCOR1 IGF2BP2 ARNT KMT2D LMAN1 AKAP9 ARID2 GMEB1 EIF5B ATF1 LSM14B RPA2 TOP2B | 2.69e-08 | 1245 | 202 | 35 | int:CEBPA |
| Interaction | NFYC interactions | SP1 SP2 SP4 GON4L POGZ NFRKB NFYA NFYC EP400 ADNP2 POU6F1 USF3 ARID2 | 2.84e-08 | 177 | 202 | 13 | int:NFYC |
| Interaction | TBP interactions | BDP1 SP1 SP3 GPBP1 DHX9 NFYA NFYC TAF4B GTF2A1L RELA CREBBP CREM GTF2A1 ZNF76 RPL3 | 4.24e-08 | 253 | 202 | 15 | int:TBP |
| Interaction | SOX9 interactions | 4.83e-08 | 97 | 202 | 10 | int:SOX9 | |
| Interaction | HNF1B interactions | SOX5 POGZ TRRAP BPTF NFRKB EP400 CREB1 CREBBP NCOR1 KMT2D ARID2 ATF1 RPA2 | 6.58e-08 | 190 | 202 | 13 | int:HNF1B |
| Interaction | POGZ interactions | SOX5 SP1 SP3 SP4 POGZ QRICH1 PLIN2 ODAM NFYA NFYC FNDC3B ADNP2 CREB1 ZNF76 RPA2 | 7.81e-08 | 265 | 202 | 15 | int:POGZ |
| Interaction | USP7 interactions | ANKRD31 SP1 SP3 SP4 CDH26 SALL3 PSMA5 HSPH1 GON4L KEAP1 TSC22D2 TRRAP DHX9 FAM186A GPC4 USP7 NAV2 GOLGB1 DRP2 ANK1 COBLL1 RELA CREB1 CREBBP KMT2D SF3B3 SLC20A1 ZNF335 CEP250 ZNF76 KIF13A RPA2 HERPUD1 TOP2B ZC3HAV1 | 9.96e-08 | 1313 | 202 | 35 | int:USP7 |
| Interaction | FBXW7 interactions | MYCBP2 RPS5 PSMA5 GATB POGZ GFPT1 DHX9 MEP1A MED24 HERC2 MED12 KPNA3 IL24 MMS22L POLR1A EP400 MED29 PUF60 LAMB3 RELA KANK2 NCOR1 IGF2BP2 KMT2D SF3B3 MTOR EIF5B SPRED1 LSM14B NHEJ1 PUM1 RPL3 TOP2B | 1.59e-07 | 1215 | 202 | 33 | int:FBXW7 |
| Interaction | YAP1 interactions | RPS5 PSMA5 HSPH1 POGZ RRBP1 TRRAP DHX9 BPTF PRRC2C NUFIP2 NFRKB GPC4 USP7 TOLLIP MED12 ZBTB33 ANK3 AHCTF1 VPS4B RELA CREB1 CREBBP PKNOX2 NCOR1 ARNT KMT2D SF3B3 ARID2 NFAT5 RPA2 TUBAL3 | 1.62e-07 | 1095 | 202 | 31 | int:YAP1 |
| Interaction | CREBBP interactions | SP1 SP3 GPBP1 TRRAP NFYA USP7 SYT1 NPAS2 RAD23A RELA CREB1 CREBBP CREM TFDP1 HIPK3 NCOR1 ARNT KMT2D GMEB1 ATF1 RPA2 RPL3 | 1.68e-07 | 599 | 202 | 22 | int:CREBBP |
| Interaction | YY1 interactions | SP1 SP3 GON4L POGZ TRRAP BPTF PHC3 NUFIP2 NFRKB USP7 EP400 RELA CREB1 CREBBP TFDP1 FOXP4 MTOR ARID2 RPA2 | 1.70e-07 | 454 | 202 | 19 | int:YY1 |
| Interaction | WWTR1 interactions | MYCBP2 POGZ KEAP1 TRRAP BPTF PRRC2C USP7 ZBTB33 ANK3 EP400 PUF60 AHCTF1 CREBBP NCOR1 ARNT KMT2D ARID2 ZC3HAV1 | 2.76e-07 | 422 | 202 | 18 | int:WWTR1 |
| Interaction | CREB1 interactions | SP1 HSPH1 POGZ NFYA USP7 TOLLIP CREB1 CREBBP CREM HIPK3 NCOR1 GTF2A1 ARNT ATF1 | 2.97e-07 | 254 | 202 | 14 | int:CREB1 |
| Interaction | SP4 interactions | 3.52e-07 | 46 | 202 | 7 | int:SP4 | |
| Interaction | ETS1 interactions | 3.95e-07 | 121 | 202 | 10 | int:ETS1 | |
| Interaction | SIRT7 interactions | MYCBP2 RPS5 NOL6 POGZ TRRAP GFPT1 BPTF PRRC2C NUFIP2 USP7 HERC2 ANKRD52 MED12 WDR36 POLR1A PUF60 AHCTF1 IGF2BP2 MTOR HELZ2 EIF5B PUM1 RPL3 ZC3HAV1 | 4.77e-07 | 744 | 202 | 24 | int:SIRT7 |
| Interaction | PPARG interactions | SP1 DHX9 MED24 USP7 SYT1 RELA CREBBP NCOR1 KMT2D SF3B3 ARID2 HELZ2 RPA2 TOP2B ZC3HAV1 | 5.19e-07 | 307 | 202 | 15 | int:PPARG |
| Interaction | ELF1 interactions | 5.75e-07 | 126 | 202 | 10 | int:ELF1 | |
| Interaction | SOX2 interactions | SOX5 ZNF384 SP2 SALL3 PSMA5 POGZ DHX9 BPTF PHC3 NEU2 INTS2 NUFIP2 GPC4 USP7 NAV2 TOLLIP KPNA4 WDR36 EP400 BAZ2B PUF60 MRPL28 CREB1 NCOR1 FOXP4 IGF2BP2 ARNT KMT2D ARID2 HELZ2 EIF5B ATF1 LSM14B RPA2 RPL3 | 6.62e-07 | 1422 | 202 | 35 | int:SOX2 |
| Interaction | PML interactions | SP1 SP2 SP3 SPTA1 QRICH1 RRBP1 MED24 NUFIP2 NFRKB USP7 POLK CEP97 KPNA4 ANKFY1 ZBTB33 WDR36 EP400 RELA CREBBP NCOR1 ARNT MTOR PAWR LSM14B RPL3 TOP2B ZC3HAV1 | 7.31e-07 | 933 | 202 | 27 | int:PML |
| Interaction | SP1 interactions | SP1 SP2 SP3 SP4 HSPH1 POGZ KEAP1 NFYA USP7 NFYC RELA CREB1 CREBBP NCOR1 GTF2A1 ARNT | 9.10e-07 | 365 | 202 | 16 | int:SP1 |
| Interaction | RAD51 interactions | SP1 MYCBP2 SPTA1 KEAP1 POLK IL24 MMS22L EP400 KIF21A RELA ARID2 GMEB1 RPA2 | 1.01e-06 | 241 | 202 | 13 | int:RAD51 |
| Interaction | NFYA interactions | 1.12e-06 | 105 | 202 | 9 | int:NFYA | |
| Interaction | KLF8 interactions | SOX5 SP1 RPS5 PSMA5 HSPH1 POGZ BPTF PRRC2C NFRKB EP400 CREBBP TFDP1 FOXP4 KMT2D ARID2 | 1.24e-06 | 329 | 202 | 15 | int:KLF8 |
| Interaction | ATF7IP interactions | 1.33e-06 | 138 | 202 | 10 | int:ATF7IP | |
| Interaction | ATOH1 interactions | 1.39e-06 | 80 | 202 | 8 | int:ATOH1 | |
| Interaction | MEN1 interactions | ZNF384 PSMA5 NOL6 POGZ TRRAP DHX9 MED24 BPTF NUFIP2 MED12 RAD23A KPNA3 WDR36 EP400 AHCTF1 MRPL28 RELA NCOR1 IGF2BP2 KMT2D PAXBP1 ARID2 EIF5B PUM1 RPA2 RPL3 TOP2B ZC3HAV1 | 1.50e-06 | 1029 | 202 | 28 | int:MEN1 |
| Interaction | NANOG interactions | SP1 SALL3 NOL6 POGZ TRRAP DHX9 BPTF NUFIP2 USP7 MED12 EP400 AHCTF1 RELA PHC1 NCOR1 ARNT AKAP9 PUM1 | 1.82e-06 | 481 | 202 | 18 | int:NANOG |
| Interaction | HDAC2 interactions | SP1 SP3 MYCBP2 UBQLN4 GFPT1 BPTF PRRC2C NUFIP2 HERC2 GOLGA4 KPNA3 KPNA4 EP400 RELA CPS1 CREB1 CREBBP TFDP1 PHC1 NCOR1 HELZ2 RPA2 RPL3 TOP2B ZC3HAV1 | 2.00e-06 | 865 | 202 | 25 | int:HDAC2 |
| Interaction | RELA interactions | SP1 SP3 KEAP1 DHX9 GLG1 NUFIP2 GPC4 USP7 TAF4B KPNA3 KPNA4 ZBTB33 POLR1A EEF1AKMT3 RELA CREBBP ARNT KMT2D | 2.04e-06 | 485 | 202 | 18 | int:RELA |
| Interaction | LHX3 interactions | SOX5 POGZ QRICH1 NFRKB KANK2 CREBBP NCOR1 FOXP4 KMT2D ARID2 ZNF76 | 2.75e-06 | 185 | 202 | 11 | int:LHX3 |
| Interaction | KDM1A interactions | MYCBP2 UBQLN4 FYCO1 POGZ KEAP1 TRRAP PHC3 INTS2 USP7 ANKRD52 MED12 GOLGB1 ANKFY1 ZBTB33 EP400 VPS4B RELA TFDP1 PHC1 NCOR1 KMT2D LLGL2 LMAN1 AKAP9 UBE3C RPA2 | 2.80e-06 | 941 | 202 | 26 | int:KDM1A |
| Interaction | H3-4 interactions | GPBP1 SPTA1 POGZ KDM5D TRRAP BPTF PHC3 PRRC2C TAF4B HERC2 POLK MMS22L KIF21A CREB1 CREBBP USF3 SYNE3 | 2.95e-06 | 448 | 202 | 17 | int:H3-4 |
| Interaction | NFIX interactions | SOX5 POGZ QRICH1 TRRAP BPTF NFRKB EP400 CREB1 TFDP1 NCOR1 KMT2D ARID2 | 3.29e-06 | 227 | 202 | 12 | int:NFIX |
| Interaction | H3C1 interactions | GPBP1 NOL6 POGZ RRBP1 TRRAP ITIH2 BPTF PRRC2C USP7 NAV2 MAPRE2 MMS22L ANK3 AHCTF1 COBLL1 MRPL28 CREB1 CREBBP DNAH1 NCOR1 KMT2D ARID2 RPA2 RPL3 TOP2B | 4.11e-06 | 901 | 202 | 25 | int:H3C1 |
| Interaction | BAG2 interactions | SP1 QRICH1 BPTF PHC3 PRRC2C NFRKB NFYC MAPRE2 MED12 EEF1AKMT3 LAMB3 RELA CREBBP PHC1 NCOR1 ARNT LMAN1 PUM1 RPA2 MAP2K5 | 4.79e-06 | 622 | 202 | 20 | int:BAG2 |
| Interaction | NUP43 interactions | NOL6 GON4L POGZ BPTF PHC3 PRRC2C NFRKB MED12 WDR36 EP400 BAZ2B AHCTF1 TFDP1 NCOR1 KMT2D PAXBP1 ARID2 CEP250 RPL3 TOP2B | 5.15e-06 | 625 | 202 | 20 | int:NUP43 |
| Interaction | ADAR interactions | NOL6 POGZ DHX9 USP7 TOLLIP EP400 PUF60 SF3B3 HELZ2 RPA2 RPL3 TOP2B TUBAL3 | 6.68e-06 | 286 | 202 | 13 | int:ADAR |
| Interaction | LHX4 interactions | 7.01e-06 | 166 | 202 | 10 | int:LHX4 | |
| Interaction | AR interactions | SP1 MYCBP2 RPS5 TRRAP DHX9 MED24 NFRKB USP7 TOLLIP MED12 ZBTB33 EP400 PUF60 RELA CREB1 CREBBP HIPK3 NCOR1 FOXP4 ARNT KMT2D PAXBP1 SF3B3 ARID2 RPL3 TOP2B | 7.21e-06 | 992 | 202 | 26 | int:AR |
| Interaction | KCNA3 interactions | RPS5 HSPH1 FYCO1 KEAP1 RRBP1 GFPT1 DHX9 KCNA6 PRRC2C NUFIP2 MAPRE2 MED12 GOLGA4 GOLGB1 ZBTB33 ANK3 PUF60 AHCTF1 COBLL1 SF3B3 LMAN1 EIF5B RPL3 ZC3HAV1 | 7.31e-06 | 871 | 202 | 24 | int:KCNA3 |
| Interaction | BRCA1 interactions | SP1 RPS5 PSMA5 HSPH1 KEAP1 MAP3K1 TULP2 DHX9 BPTF NUFIP2 NFYA USP7 HERC2 MED12 KPNA3 MMS22L POLR1A RELA CREB1 CREBBP ARNT SF3B3 MTOR EIF5B ATF1 UBE3C RPA2 RPL3 TOP2B ZC3HAV1 | 7.54e-06 | 1249 | 202 | 30 | int:BRCA1 |
| Interaction | PARP1 interactions | ZNF384 SP1 MYCBP2 SPTA1 NOL6 GATB POGZ QRICH1 TRRAP MED24 BPTF PHC3 NFYA USP7 NFYC RAD23A KPNA3 IL24 FNDC3B WDR36 POLR1A EP400 MRPL28 RELA KANK2 CREBBP PHC1 MTOR RPA2 RPL3 TOP2B | 7.70e-06 | 1316 | 202 | 31 | int:PARP1 |
| Interaction | MKI67 interactions | SMG1 ZNF384 SP1 RPS5 QRICH1 RRBP1 TRRAP MED24 RPS6KA6 NAV2 TOLLIP MED12 KPNA4 WDR36 EP400 LAMB3 FOXP4 KMT2D PAXBP1 RPA2 | 8.77e-06 | 648 | 202 | 20 | int:MKI67 |
| Interaction | UBE2I interactions | SOX5 SP3 NOL6 UBQLN4 MAP3K1 DHX9 RPS6KA6 RUSF1 GOLGB1 KPNA4 PUF60 CREB1 CREBBP CREM PHC1 HIPK3 NCOR1 ARNT GMEB1 TOP2B | 1.00e-05 | 654 | 202 | 20 | int:UBE2I |
| Interaction | GTF2A1 interactions | 1.00e-05 | 104 | 202 | 8 | int:GTF2A1 | |
| Interaction | TOP3B interactions | ZNF384 MYCBP2 FYCO1 PLXND1 ZNF236 TRRAP DHX9 PROM2 NUFIP2 GPC4 USP7 NAV2 HERC2 MED12 WDR36 EP400 PUF60 LAMB3 KANK2 NCOR1 IGF2BP2 KMT2D LLGL2 SYNE3 MTOR ZNF335 HELZ2 UBE3C LSM14B PUM1 RPA2 ZC3HAV1 TJP3 | 1.03e-05 | 1470 | 202 | 33 | int:TOP3B |
| Interaction | ARNT interactions | SP1 RPS5 TRRAP HERC2 NPAS2 KPNA3 RELA CREB1 CREBBP NCOR1 ARNT MAP2K5 | 1.07e-05 | 255 | 202 | 12 | int:ARNT |
| Interaction | BMI1 interactions | NOL6 RRBP1 PHC3 PRRC2C NUFIP2 USP7 MED12 SCAF8 CREBBP PHC1 IGF2BP2 PAXBP1 AKAP9 HELZ2 PAWR ATF1 LSM14B PUM1 RPA2 ZC3HAV1 | 1.12e-05 | 659 | 202 | 20 | int:BMI1 |
| Interaction | CSNK2A1 interactions | BDP1 SP1 RPS5 HSPH1 KEAP1 TRRAP PRRC2C NFYA USP7 KPNA4 GTF2A1L POLR1A RELA KANK2 CREB1 CREBBP CREM PHC1 NCOR1 GTF2A1 ARNT LLGL2 EIF5B ATF1 RPA2 | 1.14e-05 | 956 | 202 | 25 | int:CSNK2A1 |
| Interaction | CDK6 interactions | SOX5 POGZ KEAP1 NEU2 ANKRD12 EEF1AKMT3 TFDP1 ARNT ZNF335 RPA2 MAP2K5 | 1.16e-05 | 215 | 202 | 11 | int:CDK6 |
| Interaction | HMGA2 interactions | 1.21e-05 | 140 | 202 | 9 | int:HMGA2 | |
| Interaction | HSF1 interactions | HSPH1 NOL6 TRRAP DHX9 MED24 NUFIP2 USP7 MAPRE2 GOLGB1 KPNA3 KPNA4 EP400 EEF1AKMT3 RELA CREBBP SF3B3 EIF5B PUM1 RPL3 | 1.28e-05 | 609 | 202 | 19 | int:HSF1 |
| Interaction | MECP2 interactions | SP1 SP3 MYCBP2 RPS5 NOL6 POGZ TRRAP DHX9 BPTF PRPF40B NUFIP2 GPC4 USP7 MED12 NPAS2 KPNA3 KPNA4 WDR36 EP400 PUF60 CREB1 NCOR1 IGF2BP2 PAXBP1 SF3B3 ARID2 HELZ2 EIF5B RPL3 TOP2B | 1.35e-05 | 1287 | 202 | 30 | int:MECP2 |
| Interaction | TRIM33 interactions | CNKSR1 HSPH1 POGZ RRBP1 TRRAP DHX9 BPTF USP7 RPS6KA6 GOLGB1 CPS1 CREBBP NCOR1 EIF5B RPA2 UNC80 | 1.42e-05 | 453 | 202 | 16 | int:TRIM33 |
| Interaction | CIC interactions | SOX5 ZNF384 RPS5 HSPH1 NOL6 POGZ DHX9 USP7 NFYC KPNA3 KPNA4 ZBTB33 EP400 CREB1 TFDP1 ARNT SF3B3 ATF1 NFAT5 RPA2 | 1.52e-05 | 673 | 202 | 20 | int:CIC |
| Interaction | MOV10 interactions | SMG1 GPBP1 RPS5 NOL6 FYCO1 POGZ QRICH1 ZC3H3 DHX9 PRRC2C NFYA ANKRD52 GOLGA4 POLR1A MED29 PUF60 SCAF8 AHCTF1 KIF21A ADNP2 AGGF1 IGF2BP2 PAXBP1 MTOR CEP250 ZNF76 LSM14B PUM1 RPA2 ZC3HAV1 | 1.56e-05 | 1297 | 202 | 30 | int:MOV10 |
| Interaction | HUWE1 interactions | MYCBP2 RPS5 PSMA5 HSPH1 KEAP1 BPTF USP7 MAPRE2 ANKRD52 RAD23A KPNA3 KPNA4 ANKFY1 ZBTB33 EEF1AKMT3 KIF21A KANK2 CREBBP GTF2A1 SF3B3 AKAP9 CEP250 HELZ2 LSM14B KIF13A RPA2 RPL3 | 1.81e-05 | 1110 | 202 | 27 | int:HUWE1 |
| Interaction | CEBPB interactions | ZNF384 SP1 SP3 RPS5 PSMA5 HSPH1 QRICH1 RRBP1 DHX9 BPTF PHC3 PRRC2C NUFIP2 USP7 NFYC KPNA4 ZBTB33 AHCTF1 RELA CREB1 CREBBP ARHGAP4 NCOR1 GTF2A1 IGF2BP2 KMT2D SF3B3 AKAP9 EIF5B NFAT5 RPA2 RPL3 | 1.83e-05 | 1443 | 202 | 32 | int:CEBPB |
| Interaction | DEPTOR interactions | 1.84e-05 | 82 | 202 | 7 | int:DEPTOR | |
| Interaction | HECTD1 interactions | MYCBP2 RPS5 HSPH1 NOL6 KEAP1 RRBP1 TRRAP MAP3K1 DHX9 BPTF PRRC2C NUFIP2 TOLLIP HERC2 MED12 WDR36 POLR1A SCAF8 AGGF1 IGF2BP2 PAXBP1 ARID2 UBE3C TOP2B ZC3HAV1 | 1.86e-05 | 984 | 202 | 25 | int:HECTD1 |
| Interaction | G3BP2 interactions | MYCBP2 RPS5 HSPH1 NOL6 RRBP1 TRRAP DHX9 PRRC2C NUFIP2 USP7 MED12 WDR36 IGF2BP2 PUM1 RPL3 TOP2B ZC3HAV1 | 1.97e-05 | 518 | 202 | 17 | int:G3BP2 |
| Interaction | CIT interactions | ZNF384 RPS5 NOL6 POGZ PLXND1 TRRAP GFPT1 DHX9 BPTF PRRC2C NUFIP2 GOLGA4 KPNA3 WDR36 POLR1A EP400 PUF60 AHCTF1 MRPL28 CPS1 IGF2BP2 PAXBP1 SF3B3 OR4C15 LMAN1 AKAP9 EIF5B RPL3 NACA4P TOP2B TUBAL3 ZC3HAV1 | 2.01e-05 | 1450 | 202 | 32 | int:CIT |
| Interaction | RNF2 interactions | NOL6 POGZ TSC22D2 TRRAP DHX9 MED24 PHC3 GLG1 USP7 ZBTB33 WDR36 POLR1A ANK3 EP400 RELA TFDP1 PHC1 KMT2D SF3B3 AKAP9 RPL3 TUBAL3 ZC3HAV1 | 2.06e-05 | 866 | 202 | 23 | int:RNF2 |
| Interaction | PAX6 interactions | SOX5 FYCO1 POGZ QRICH1 BPTF NFRKB NFYC EP400 KANK2 CREBBP TFDP1 NCOR1 KMT2D ARID2 | 2.07e-05 | 366 | 202 | 14 | int:PAX6 |
| Interaction | ELF4 interactions | 2.10e-05 | 115 | 202 | 8 | int:ELF4 | |
| Interaction | SP3 interactions | 2.16e-05 | 84 | 202 | 7 | int:SP3 | |
| Interaction | HNF4A interactions | SP1 POGZ TRRAP MED24 BPTF NFRKB EP400 CREBBP NCOR1 ARNT KMT2D ARID2 | 2.28e-05 | 275 | 202 | 12 | int:HNF4A |
| Interaction | SQSTM1 interactions | SMG1 ZNF384 ZNF274 GPBP1 RPS5 HSPH1 KEAP1 RRBP1 DHX9 BPTF GLG1 GPC4 TOLLIP MAPRE2 GOLGB1 RAD23A KPNA3 KPNA4 RELA NCOR1 LLGL2 SYNE3 MTOR CEP250 EIF5B PAWR RPA2 MAP2K5 ZC3HAV1 | 2.31e-05 | 1257 | 202 | 29 | int:SQSTM1 |
| Interaction | POU5F1 interactions | SOX5 SP1 SALL3 TRRAP DHX9 BPTF NFRKB USP7 NFYC KPNA3 EP400 SCAF8 CREB1 PHC1 FOXP4 EIF5B LSM14B TOP2B | 2.56e-05 | 584 | 202 | 18 | int:POU5F1 |
| Interaction | KLF16 interactions | SOX5 RPS5 PSMA5 HSPH1 GON4L POGZ PRRC2C NFRKB POLK ZBTB33 EP400 TFDP1 KMT2D ARID2 RPA2 | 2.68e-05 | 425 | 202 | 15 | int:KLF16 |
| Interaction | TLE3 interactions | QRICH1 PHC3 PRPF40B NFRKB ANK3 BAZ2B SCAF8 CREBBP NCOR1 ARNT KMT2D PAXBP1 ARID2 RPA2 | 2.79e-05 | 376 | 202 | 14 | int:TLE3 |
| Interaction | TAF4 interactions | 2.86e-05 | 156 | 202 | 9 | int:TAF4 | |
| Interaction | NXF1 interactions | SP1 GPBP1 RPS5 NOL6 UBQLN4 POGZ QRICH1 TRRAP ZC3H3 DHX9 NFYA ANKRD52 KPNA3 KPNA4 WDR36 POLR1A SCAF8 AHCTF1 VPS4B KIF21A ADNP2 AGGF1 PAXBP1 MTOR SLC20A1 CEP250 ZNF76 RPA2 MAP2K5 ZC3HAV1 | 3.10e-05 | 1345 | 202 | 30 | int:NXF1 |
| Interaction | NFE2L2 interactions | 3.33e-05 | 159 | 202 | 9 | int:NFE2L2 | |
| Interaction | POLR1G interactions | ZNF384 POGZ TRRAP BPTF PHC3 USP7 TOLLIP KPNA3 KPNA4 WDR36 POLR1A EP400 BAZ2B RELA RPL3 TOP2B | 3.60e-05 | 489 | 202 | 16 | int:POLR1G |
| Interaction | TAF6 interactions | SOX5 PSMA5 TRRAP NFYA NFYC GOLGA4 RELA NCOR1 GTF2A1 SF3B3 RPA2 | 3.87e-05 | 245 | 202 | 11 | int:TAF6 |
| Interaction | HIF1A interactions | SP1 KEAP1 TRRAP USP7 MED12 KPNA3 KPNA4 EP400 RELA CREB1 CREBBP ARNT MTOR UBE3C MAP2K5 | 4.09e-05 | 441 | 202 | 15 | int:HIF1A |
| Interaction | SP2 interactions | 4.20e-05 | 39 | 202 | 5 | int:SP2 | |
| Interaction | DEAF1 interactions | 4.35e-05 | 64 | 202 | 6 | int:DEAF1 | |
| Interaction | RB1 interactions | BDP1 SP1 SP3 UNC13D KEAP1 USP7 ANKRD52 KPNA3 KPNA4 CREBBP TFDP1 NCOR1 ARNT RPA2 | 4.64e-05 | 394 | 202 | 14 | int:RB1 |
| Interaction | NAA40 interactions | ZNF384 HSPH1 KEAP1 RRBP1 GFPT1 PHC3 PRRC2C NUFIP2 USP7 MAPRE2 GOLGB1 ZBTB33 WDR36 EP400 PUF60 AHCTF1 GTF2A1 IGF2BP2 ARID2 EIF5B RPA2 RPL3 TOP2B ZC3HAV1 | 4.79e-05 | 978 | 202 | 24 | int:NAA40 |
| Interaction | C22orf15 interactions | 5.13e-05 | 21 | 202 | 4 | int:C22orf15 | |
| Interaction | POLR1E interactions | POGZ TRRAP PHC3 WDR36 POLR1A BAZ2B RELA CREBBP TFDP1 EIF5B RPA2 RPL3 TOP2B | 5.55e-05 | 350 | 202 | 13 | int:POLR1E |
| Interaction | UBAP2 interactions | 5.61e-05 | 170 | 202 | 9 | int:UBAP2 | |
| Interaction | EGR2 interactions | 5.87e-05 | 171 | 202 | 9 | int:EGR2 | |
| Interaction | DOT1L interactions | RPS5 PSMA5 NOL6 TRRAP DHX9 WDR36 POLR1A PUF60 AHCTF1 CPS1 KANK2 IGF2BP2 PAXBP1 SF3B3 ARID2 UBE3C PUM1 NFAT5 RPL3 TOP2B ZC3HAV1 | 6.44e-05 | 807 | 202 | 21 | int:DOT1L |
| Interaction | LSM14A interactions | SOX5 SMG1 MYCBP2 DHX9 PRRC2C NUFIP2 IGF2BP2 LSM14B PUM1 MAP2K5 ZC3HAV1 | 6.62e-05 | 260 | 202 | 11 | int:LSM14A |
| Interaction | H3-3A interactions | ZNF384 POGZ TRRAP BPTF NFRKB USP7 HERC2 POLK KPNA3 KPNA4 PUF60 AHCTF1 ADNP2 CREBBP TFDP1 KMT2D ARID2 PAWR RPA2 TOP2B | 6.82e-05 | 749 | 202 | 20 | int:H3-3A |
| Interaction | SMARCA4 interactions | SP1 SPTA1 RRBP1 TRRAP BPTF USP7 KPNA3 EP400 CREB1 CREBBP NCOR1 SF3B3 ARID2 RPA2 TOP2B | 6.92e-05 | 462 | 202 | 15 | int:SMARCA4 |
| Interaction | POU2F1 interactions | 7.02e-05 | 175 | 202 | 9 | int:POU2F1 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 3.86e-07 | 9 | 137 | 4 | 755 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.53e-05 | 25 | 137 | 4 | 775 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.20e-04 | 18 | 137 | 3 | 91 | |
| GeneFamily | PHD finger proteins | 6.09e-04 | 90 | 137 | 5 | 88 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 6.93e-04 | 53 | 137 | 4 | 532 | |
| GeneFamily | Cyclins|Mediator complex | 1.97e-03 | 33 | 137 | 3 | 1061 | |
| GeneFamily | Ankyrin repeat domain containing | 2.49e-03 | 242 | 137 | 7 | 403 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF384 SP1 SP2 SP3 SP4 SALL3 ZNF274 ZNF236 ZBTB33 ADNP2 ZNF335 ZNF76 ZSCAN23 | 3.19e-03 | 718 | 137 | 13 | 28 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SP1 SP2 GPBP1 MYCBP2 PSMA5 UBQLN4 QRICH1 KEAP1 ZC3H3 NUFIP2 TOLLIP ANKRD52 GOLGA4 RAD23A KPNA3 KPNA4 ANKFY1 PUF60 AGGF1 MRPL28 CREBBP ARNT LMAN1 MTOR EIF5B UBE3C LSM14B RPA2 | 6.98e-08 | 1129 | 205 | 28 | M42508 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SP1 SP2 GPBP1 MYCBP2 PSMA5 UBQLN4 QRICH1 KEAP1 ZC3H3 NUFIP2 TOLLIP ANKRD52 GOLGA4 RAD23A KPNA3 KPNA4 ANKFY1 PUF60 AGGF1 MRPL28 CREBBP ARNT LMAN1 MTOR EIF5B UBE3C LSM14B RPA2 | 1.18e-07 | 1158 | 205 | 28 | MM1338 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | SP2 ZNF274 HSPH1 GON4L TSC22D2 GFPT1 PLIN2 NFYA NAV2 ANKRD12 GOLGB1 IL24 BAZ2B VPS4B ADNP2 CREBBP HIPK3 AKAP9 GMEB1 PUM1 NFAT5 HERPUD1 ZC3HAV1 | 1.40e-07 | 822 | 205 | 23 | M6782 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 SMG1 SP3 GPBP1 MYCBP2 UNC13D ITGB7 DHX9 BPTF PHC3 GLG1 NUFIP2 MAPRE2 KPNA4 EP400 SCAF8 AGGF1 CREB1 CREBBP CREM ARHGAP4 NCOR1 KMT2D SF3B3 AKAP9 SLC20A1 ARID2 NFAT5 RPA2 TOP2B ZC3HAV1 SP140 | 2.05e-07 | 1492 | 205 | 32 | M40023 |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION | 3.74e-06 | 82 | 205 | 7 | M16458 | |
| Coexpression | GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | FYCO1 TOLLIP MAPRE2 POLR1A EP400 MED29 ADNP2 CREM MTOR EIF5B | 3.89e-06 | 198 | 205 | 10 | M4249 |
| Coexpression | GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_UP | SMG1 ACOX1 ITGB7 SNX13 NFRKB ANKRD12 TAF4B POU6F1 CREBBP RPL3 | 4.26e-06 | 200 | 205 | 10 | M6367 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MYCBP2 TRRAP SNX13 BPTF PRRC2C NFYC GOLGA4 KPNA3 BAZ2B SCAF8 CREB1 CREBBP AKAP9 PAWR PUM1 | 4.42e-06 | 466 | 205 | 15 | M13522 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | ZNF274 GON4L QRICH1 KDM5D PRRC2C NUFIP2 NFYA GOLGA4 RAD23A BAZ2B ADNP2 CREBBP TFDP1 NCOR1 PUM1 | 4.53e-06 | 467 | 205 | 15 | M1347 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | SP2 SP3 PSMA5 ITGB7 MAP3K1 DHX9 BPTF KCNA6 PRRC2C SCNN1B TAF4B IL24 ZBTB33 EP400 VPS4B AGGF1 PCDHA12 POU6F1 TFDP1 HIPK3 ARHGAP4 GTF2A1 ARNT EIF5B RPA2 TOP2B ZC3HAV1 SP140 | 4.54e-06 | 1394 | 205 | 28 | M9585 |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION | 4.76e-06 | 85 | 205 | 7 | MM1106 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | MYCBP2 HSPH1 GFPT1 NAV2 ANKRD12 MAPRE2 GOLGA4 GOLGB1 ZBTB33 AHCTF1 COBLL1 KIF21A USF3 LMAN1 ABCA5 FMN2 UBE3C KIF13A RPA2 RPL3 HERPUD1 UNC80 | 5.53e-06 | 946 | 205 | 22 | M39169 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | ZNF274 GON4L QRICH1 KDM5D PRRC2C NUFIP2 NFYA GOLGA4 RAD23A BAZ2B ADNP2 CREBBP TFDP1 NCOR1 PUM1 | 6.96e-06 | 484 | 205 | 15 | MM999 |
| Coexpression | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER | 9.30e-06 | 94 | 205 | 7 | M18108 | |
| Coexpression | SENESE_HDAC1_TARGETS_UP | BDP1 PLIN2 DHX9 NFYA NPAS2 KPNA4 IL24 AHCTF1 COBLL1 LAMB3 CREM IGF2BP2 LMAN1 SPRED1 | 1.39e-05 | 451 | 205 | 14 | M14973 |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 1.91e-05 | 189 | 205 | 9 | M3112 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C6_SECRETORY_PROGENITOR | 2.38e-05 | 22 | 205 | 4 | M39156 | |
| Coexpression | GSE11924_TFH_VS_TH1_CD4_TCELL_UP | 2.87e-05 | 199 | 205 | 9 | M3151 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 2.98e-05 | 200 | 205 | 9 | M9449 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 MYCBP2 TSC22D2 TRRAP SNX13 BPTF PRRC2C USP7 NFYC GOLGA4 KPNA3 BAZ2B SCAF8 AHCTF1 CREB1 CREBBP AKAP9 PAWR PUM1 | 4.67e-05 | 856 | 205 | 19 | M4500 |
| Coexpression | TIEN_INTESTINE_PROBIOTICS_24HR_DN | 5.24e-05 | 215 | 205 | 9 | M19666 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 GPBP1 MYCBP2 HSPH1 SNX13 BPTF POLK GOLGA4 GOLGB1 BAZ2B AHCTF1 AGGF1 CREB1 ABCA5 EIF5B TOP2B | 6.38e-05 | 656 | 205 | 16 | M18979 |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 6.46e-05 | 54 | 205 | 5 | MM927 | |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 6.46e-05 | 54 | 205 | 5 | M2372 | |
| Coexpression | BENPORATH_SOX2_TARGETS | SP2 ACOX1 NOL6 UBQLN4 PLIN2 NUFIP2 USP7 MAPRE2 MED12 RAD23A KPNA3 WDR36 PAXBP1 ZNF335 SPRED1 PUM1 TJP3 | 7.09e-05 | 734 | 205 | 17 | M3835 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | SMG1 ZNF274 GON4L MAP3K1 DHX9 PHC3 NUFIP2 KPNA4 ANK3 AHCTF1 DNAH1 USF3 ARID2 | 9.96e-05 | 474 | 205 | 13 | M40991 |
| Coexpression | BENPORATH_NANOG_TARGETS | SP2 SALL3 NOL6 UBQLN4 TSC22D2 PLIN2 GLG1 GPC4 USP7 TAF4B MED12 GOLGA4 NPAS2 RAD23A KPNA3 WDR36 POLR1A NCOR1 SPRED1 NFAT5 | 1.04e-04 | 988 | 205 | 20 | M6616 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.35e-04 | 300 | 205 | 10 | M8702 | |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 1.45e-04 | 101 | 205 | 6 | M15356 | |
| Coexpression | GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN | 1.69e-04 | 197 | 205 | 8 | M7947 | |
| Coexpression | GSE45365_NK_CELL_VS_BCELL_UP | 1.75e-04 | 198 | 205 | 8 | M10031 | |
| Coexpression | GSE22886_TCELL_VS_BCELL_NAIVE_DN | 1.75e-04 | 198 | 205 | 8 | M4426 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP | 1.81e-04 | 199 | 205 | 8 | M4526 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP | 1.81e-04 | 199 | 205 | 8 | M6443 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 1.81e-04 | 199 | 205 | 8 | M9124 | |
| Coexpression | GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN | 1.81e-04 | 199 | 205 | 8 | M6932 | |
| Coexpression | GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN | 1.81e-04 | 199 | 205 | 8 | M6926 | |
| Coexpression | GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP | 1.87e-04 | 200 | 205 | 8 | M7060 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 1.87e-04 | 200 | 205 | 8 | M5063 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP | 1.87e-04 | 200 | 205 | 8 | M4488 | |
| Coexpression | GSE11924_TFH_VS_TH2_CD4_TCELL_UP | 1.87e-04 | 200 | 205 | 8 | M3153 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.87e-04 | 200 | 205 | 8 | M9136 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | TSC22D2 RRBP1 GLG1 POLK IL24 FNDC3B ANKFY1 WDR36 ANK1 COBLL1 LAMB3 SYNE3 ABCA5 CEP250 FMN2 SPRED1 NFAT5 HERPUD1 ZC3HAV1 SP140 | 1.88e-04 | 1033 | 205 | 20 | M4196 |
| Coexpression | GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP | 1.93e-04 | 151 | 205 | 7 | M6498 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | SP1 ACOX1 GON4L FYCO1 POGZ RRBP1 MAP3K1 PHC3 PROM2 GOLGB1 MED29 HIPK3 NCOR1 LLGL2 AKAP9 ARID2 SPRED1 | 2.19e-04 | 807 | 205 | 17 | M16651 |
| Coexpression | KYNG_DNA_DAMAGE_UP | 2.21e-04 | 205 | 205 | 8 | M3961 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | SP4 GPBP1 UBQLN4 ITIH2 DHX9 NRK NUFIP2 NFYC KPNA3 KANK2 HIPK3 ARNT EIF5B | 2.42e-04 | 519 | 205 | 13 | M3395 |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 2.77e-04 | 212 | 205 | 8 | MM3816 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | MYCBP2 RPS5 PSMA5 UNC13D QRICH1 PGC ITGB7 BPTF PRRC2C ANKRD12 MAPRE2 CREBBP CREM ARHGAP4 ARID2 RPL3 TOP2B ZC3HAV1 | 3.11e-04 | 911 | 205 | 18 | M40038 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | SOX5 SMG1 MYCBP2 GFPT1 SNX13 NRK USP7 HERC2 ADGRL3 ZBTB33 CREBBP HIPK3 AKAP9 NFAT5 TOP2B | 4.91e-07 | 330 | 197 | 15 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SOX5 SMG1 SP1 SP3 SP4 KDM5D MAP3K1 TULP2 GLG1 PRRC2C NRK USP7 NAV2 TAF4B RAD23A ANKFY1 POLR1A CREBBP PKNOX2 GMEB1 EIF5B SPRED1 PUM1 ZC3HAV1 | 4.98e-07 | 806 | 197 | 24 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SMG1 SP1 SP3 SP4 KDM5D MAP3K1 GLG1 PRRC2C NRK USP7 NAV2 ANKRD12 RAD23A ANKFY1 POLR1A BAZ2B CREBBP LMAN1 GMEB1 PTCH2 SPRED1 PUM1 NFAT5 | 1.63e-06 | 801 | 197 | 23 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | SOX5 SMG1 SP1 SP3 SPTA1 MAP3K1 TULP2 SMPX INTS2 GLG1 PRRC2C NAV2 ANKRD12 TAF4B ANKFY1 DRP2 CREBBP GMEB1 SPRED1 PUM1 NFAT5 ZC3HAV1 | 5.03e-06 | 795 | 197 | 22 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | SP1 SP3 HSPH1 KDM5D GFPT1 NRK USP7 ZBTB33 KIF21A PAXBP1 PUM1 TOP2B | 7.60e-06 | 266 | 197 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | SOX5 SMG1 MYCBP2 GFPT1 SNX13 PRRC2C NRK USP7 SYT1 HERC2 ADGRL3 ZBTB33 KIF21A CREBBP HIPK3 AKAP9 CLCA2 ABCA5 RIMS2 NFAT5 TOP2B | 2.56e-05 | 818 | 197 | 21 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274 | SALL3 HSPH1 GFPT1 NRK ADGRL3 KIF21A CREB1 GTF2A1 CLCA2 ABCA5 TOP2B | 2.87e-05 | 256 | 197 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | SMG1 MYCBP2 GON4L PRRC2C GOLGA4 ANKFY1 ANK3 HIPK3 AKAP9 ARID2 NFAT5 | 3.43e-05 | 261 | 197 | 11 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | SMG1 SP3 SPTA1 MAP3K1 PRRC2C NAV2 ANKFY1 CREBBP GMEB1 SPRED1 | 6.03e-05 | 230 | 197 | 10 | gudmap_developingGonad_e16.5_ovary_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SOX5 SP1 SP3 MAP3K1 TULP2 SMPX INTS2 PRRC2C NRK USP7 NAV2 ANKRD12 ANKFY1 DRP2 CREBBP GTF2A1 GMEB1 SPRED1 PUM1 NFAT5 | 6.23e-05 | 804 | 197 | 20 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | SMG1 SNX13 PRRC2C USP7 GOLGA4 ANK3 HIPK3 AKAP9 SLC20A1 ARID2 FMN2 NFAT5 | 8.19e-05 | 339 | 197 | 12 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.71e-04 | 261 | 197 | 10 | gudmap_developingGonad_e12.5_epididymis_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | SP3 MYCBP2 GFPT1 SNX13 PROM2 NRK HERC2 ABCG5 ADGRL3 ZBTB33 ANK3 LAMB3 KANK2 HIPK3 AKAP9 CLCA2 ABCA5 FMN2 TOP2B | 1.91e-04 | 806 | 197 | 19 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_500 | 2.17e-04 | 92 | 197 | 6 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | SMG1 MYCBP2 SMPX BPTF PRRC2C KPNA4 ANK3 HIPK3 NCOR1 AKAP9 ARID2 NFAT5 | 2.31e-04 | 379 | 197 | 12 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_500 | 2.36e-04 | 60 | 197 | 5 | gudmap_developingGonad_e12.5_ovary_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | SMG1 SP3 MAP3K1 USP7 NAV2 ANKRD12 ANKFY1 CREBBP GMEB1 SPRED1 | 2.60e-04 | 275 | 197 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | SMG1 MYCBP2 NRK USP7 HERC2 ADGRL3 ANK3 KANK2 HIPK3 AKAP9 PUM1 KIF13A | 2.67e-04 | 385 | 197 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.31e-04 | 184 | 197 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | BDP1 GPBP1 HSPH1 RRBP1 BPTF PRRC2C GOLGA4 GOLGB1 IGF2BP2 AKAP9 ARID2 PUM1 NFAT5 | 6.64e-12 | 193 | 205 | 13 | e6a688bc834f845ff64dae1be64f073eec5091a1 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 KDM5D ZC3H3 PRRC2C NAV2 GOLGA4 GOLGB1 KIF21A NCOR1 AKAP9 ABCA5 FMN2 UNC80 | 7.57e-12 | 195 | 205 | 13 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | SMG1 GPBP1 HSPH1 NUFIP2 ANKRD12 MAPRE2 GOLGB1 AHCTF1 SLC20A1 ARID2 NFAT5 ZC3HAV1 | 8.17e-11 | 188 | 205 | 12 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 KDM5D ZC3H3 PRRC2C NAV2 GOLGA4 GOLGB1 KIF21A NCOR1 AKAP9 FMN2 UNC80 | 1.25e-10 | 195 | 205 | 12 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | BDP1 SMG1 MYCBP2 BPTF PRRC2C NUFIP2 ANKRD12 GOLGA4 GOLGB1 PAXBP1 AKAP9 HELZ2 | 1.67e-10 | 200 | 205 | 12 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | SMG1 SP1 SP3 MAP3K1 PHC3 ANKRD12 CREB1 CREBBP GTF2A1 ARID2 NFAT5 | 1.14e-09 | 186 | 205 | 11 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | BDP1 GPBP1 HSPH1 RRBP1 BPTF GOLGA4 IGF2BP2 AKAP9 ARID2 PUM1 NFAT5 | 1.60e-09 | 192 | 205 | 11 | 916fbec1c7ab7969bda711886ac88e877e30c280 |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | BDP1 SMG1 BPTF PHC3 PRRC2C ANKRD12 GOLGA4 GOLGB1 ANK3 AKAP9 ABCA5 | 2.33e-09 | 199 | 205 | 11 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 PRRC2C ANKRD12 GOLGA4 GOLGB1 CREBBP NCOR1 AKAP9 EIF5B SDCBP2 | 1.73e-08 | 187 | 205 | 10 | 663991a8afe652e92363b64bcbd68c14d0307f0e |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | SALL3 TSC22D2 NRK ADAMTS17 NAV2 FNDC3B COBLL1 LLGL2 ABCA5 SLC20A1 | 1.92e-08 | 189 | 205 | 10 | 975c0f079903ae36b0ffa54e86294d42ec7697de |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | SALL3 TSC22D2 NRK ADAMTS17 NAV2 FNDC3B COBLL1 LLGL2 ABCA5 SLC20A1 | 1.92e-08 | 189 | 205 | 10 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | PSMA5 HSPH1 BPTF PRRC2C ANKRD12 GOLGA4 GOLGB1 KIF21A AKAP9 EIF5B | 3.13e-08 | 199 | 205 | 10 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | PSMA5 HSPH1 BPTF PRRC2C ANKRD12 GOLGA4 GOLGB1 BAZ2B AKAP9 EIF5B | 3.13e-08 | 199 | 205 | 10 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 1.34e-07 | 176 | 205 | 9 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-07 | 184 | 205 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.04e-07 | 185 | 205 | 9 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.67e-07 | 191 | 205 | 9 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.47e-07 | 197 | 205 | 9 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.47e-07 | 197 | 205 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-07 | 198 | 205 | 9 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.62e-07 | 198 | 205 | 9 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-07 | 199 | 205 | 9 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 3.78e-07 | 199 | 205 | 9 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 3.78e-07 | 199 | 205 | 9 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.78e-07 | 199 | 205 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 3.78e-07 | 199 | 205 | 9 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-06 | 173 | 205 | 8 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-06 | 179 | 205 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 184 | 205 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 184 | 205 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 184 | 205 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.68e-06 | 188 | 205 | 8 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-06 | 189 | 205 | 8 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.89e-06 | 190 | 205 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.25e-06 | 193 | 205 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.78e-06 | 197 | 205 | 8 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.78e-06 | 197 | 205 | 8 | b22a79a5922c865a360e2afc5506a08a512fa76a | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.78e-06 | 197 | 205 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.93e-06 | 198 | 205 | 8 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.93e-06 | 198 | 205 | 8 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | 3'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-06 | 198 | 205 | 8 | 7ad7726fc405806b1d7824f58548073ea5e0c70b | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-06 | 198 | 205 | 8 | 1fbec311f2c987ca90a023a5989128c05aa12d5c | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.93e-06 | 198 | 205 | 8 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-06 | 198 | 205 | 8 | ceede961ad9af6a3159db7efaa5087bf38aafc2d | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-06 | 198 | 205 | 8 | 4f26a60e99f42343e5af7221723e108a1a1b7827 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 4.07e-06 | 199 | 205 | 8 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.07e-06 | 199 | 205 | 8 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 4.07e-06 | 199 | 205 | 8 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.23e-06 | 200 | 205 | 8 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.23e-06 | 200 | 205 | 8 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.23e-06 | 200 | 205 | 8 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.23e-06 | 200 | 205 | 8 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.23e-06 | 200 | 205 | 8 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-05 | 168 | 205 | 7 | f5a18123f84c62211d9279e9c41e90122e4c4895 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.47e-05 | 171 | 205 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 173 | 205 | 7 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 173 | 205 | 7 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 173 | 205 | 7 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 175 | 205 | 7 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.83e-05 | 177 | 205 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-05 | 181 | 205 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 182 | 205 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 183 | 205 | 7 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-05 | 183 | 205 | 7 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 183 | 205 | 7 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 184 | 205 | 7 | 4928f0bc9d8659420680cbbc1900320b701a7cfd | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 184 | 205 | 7 | d06e6d1100aec95a30d571245c4992c5cb854ae5 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.43e-05 | 185 | 205 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 185 | 205 | 7 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-mucus_secreting_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 185 | 205 | 7 | e502ec54971f518d0cf1b619b745607a8ab5ddf3 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 186 | 205 | 7 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.52e-05 | 186 | 205 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.61e-05 | 187 | 205 | 7 | 9325cadd5f2c667d526696899e7aa36a98226d4b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-05 | 187 | 205 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 187 | 205 | 7 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 187 | 205 | 7 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.70e-05 | 188 | 205 | 7 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-05 | 189 | 205 | 7 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 2.89e-05 | 190 | 205 | 7 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | facs-BAT-Fat-3m-Lymphocytic-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 190 | 205 | 7 | c6709b6cb518c569d06fb234a0e3b0434ef08392 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-duct_epithelial_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 190 | 205 | 7 | 5b3f773380aef4773b70f0dbd74992d28e6586c6 | |
| ToppCell | facs-BAT-Fat-3m-Lymphocytic|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 190 | 205 | 7 | 8ce836bd45634b668a87e2b8d49ccaf1e43e003e | |
| ToppCell | COVID-19_Moderate-Plasmablast|World / disease group, cell group and cell class | 2.99e-05 | 191 | 205 | 7 | bb28703020c5296b65527094d2e5924348275e58 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 191 | 205 | 7 | 4fcbc214853e115608b3be7b35639247ae41c9dc | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.09e-05 | 192 | 205 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-05 | 192 | 205 | 7 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 3.09e-05 | 192 | 205 | 7 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | Epithelial|World / shred on cell class and cell subclass (v4) | 3.09e-05 | 192 | 205 | 7 | 13a3553d9a7c78535679d23d454c63fd08f7d218 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-05 | 193 | 205 | 7 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.30e-05 | 194 | 205 | 7 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.30e-05 | 194 | 205 | 7 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.41e-05 | 195 | 205 | 7 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | COVID-19_Severe-B_memory|COVID-19_Severe / disease group, cell group and cell class | 3.41e-05 | 195 | 205 | 7 | 54becd9e283639638fc5f13eddce224aed9391da | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-05 | 195 | 205 | 7 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.52e-05 | 196 | 205 | 7 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-05 | 196 | 205 | 7 | f40d10ea7714067585493fdc89744714aa427de8 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 197 | 205 | 7 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.64e-05 | 197 | 205 | 7 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.64e-05 | 197 | 205 | 7 | e3349a381723393cd255f202afedd0c99037939b | |
| ToppCell | mild-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.64e-05 | 197 | 205 | 7 | 21085d5e27b5a23a241a933058bb89f8a1fcf198 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.25e-08 | 49 | 142 | 9 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.27e-06 | 49 | 142 | 7 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Neighborhood of MLL | 1.01e-04 | 174 | 142 | 10 | GCM_MLL | |
| Drug | Napelline [5008-52-6]; Down 200; 11.2uM; HL60; HT_HG-U133A | GON4L RRBP1 NFRKB NFYA TOLLIP ANKRD12 TAF4B KPNA4 ANKFY1 RELA LMAN1 MAP2K5 | 2.19e-07 | 197 | 203 | 12 | 2522_DN |
| Drug | NSC-364372 | HSPH1 KEAP1 TRRAP SYT1 TAF4B MAPRE2 MED12 KPNA3 KPNA4 RELA CREB1 CREM PKNOX2 ARNT AKAP9 MTOR RPL3 TJP3 | 3.80e-07 | 484 | 203 | 18 | CID000435143 |
| Drug | glutamin | ZNF384 PSMA5 HSPH1 UBQLN4 GATB GFPT1 GLG1 SYT1 RAD23A CPS1 CREB1 CREBBP CREM NCOR1 MTOR PAWR NFAT5 | 9.10e-07 | 461 | 203 | 17 | CID000000738 |
| Drug | Chloroprene | SP1 POGZ QRICH1 PLXND1 ITGB7 ITIH2 PLIN2 BPTF KCNA6 USP7 NAV2 TOLLIP ANKRD12 ANKRD52 ADGRL3 NPAS2 BAZ2B SGCB CPM CREBBP HIPK3 PKNOX2 ARHGAP4 NCOR1 IGF2BP2 AKAP9 ARID2 EIF5B PUM1 SDCBP2 TJP3 | 1.17e-06 | 1348 | 203 | 31 | ctd:D002737 |
| Drug | SP 0 | 1.24e-06 | 10 | 203 | 4 | CID002742752 | |
| Drug | Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; HL60; HT_HG-U133A | SP1 ACOX1 NOL6 ZNF236 DHX9 PHC3 NFYA TAF4B CREB1 SF3B3 EIF5B | 1.58e-06 | 196 | 203 | 11 | 2951_DN |
| Drug | Cytisine (-) [485-35-8]; Down 200; 21uM; HL60; HG-U133A | HSPH1 GON4L POGZ QRICH1 ITGAX ZC3H3 NFRKB BAZ2B EIF5B NFAT5 MAP2K5 | 1.75e-06 | 198 | 203 | 11 | 1766_DN |
| Drug | Stallimycin | 7.40e-06 | 80 | 203 | 7 | CID000003115 | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 9.21e-06 | 192 | 203 | 10 | 7176_DN | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A | TSC22D2 PHC3 NFYA CEP97 ANKFY1 COBLL1 ARHGAP4 ARNT MTOR ZNF76 | 1.01e-05 | 194 | 203 | 10 | 2284_DN |
| Drug | AC1L1DBR | 1.04e-05 | 33 | 203 | 5 | CID000002279 | |
| Drug | Dipyridamole [58-32-2]; Down 200; 8uM; HL60; HG-U133A | 1.06e-05 | 195 | 203 | 10 | 2017_DN | |
| Drug | Estrone [53-16-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | CNKSR1 GON4L RRBP1 MAP3K1 SNX13 NFYA AKAP9 LSM14B NFAT5 MAP2K5 | 1.10e-05 | 196 | 203 | 10 | 4993_DN |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A | TSC22D2 GLG1 NFYA NPAS2 ANKFY1 AGGF1 RELA NCOR1 AKAP9 MAP2K5 | 1.15e-05 | 197 | 203 | 10 | 2124_DN |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; HL60; HG-U133A | 1.15e-05 | 197 | 203 | 10 | 1977_UP | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; MCF7; HT_HG-U133A | CNKSR1 MAP3K1 TOLLIP GOLGB1 COBLL1 LAMB3 PKNOX2 GTF2A1 ARNT MAP2K5 | 1.21e-05 | 198 | 203 | 10 | 6502_DN |
| Drug | BIX 02189 | 1.37e-05 | 6 | 203 | 3 | ctd:C533207 | |
| Drug | Bouin's solution | 1.89e-05 | 62 | 203 | 6 | CID000124013 | |
| Drug | Clorgyline | 2.08e-05 | 168 | 203 | 9 | ctd:D003010 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; HL60; HT_HG-U133A | 2.18e-05 | 169 | 203 | 9 | 2193_UP | |
| Drug | CV-1 | 2.27e-05 | 213 | 203 | 10 | CID000130105 | |
| Drug | Bisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.39e-05 | 171 | 203 | 9 | 3297_UP | |
| Drug | Glucose | SP1 RPS5 NOL6 KEAP1 RRBP1 GFPT1 MAP3K1 MED24 NRK SYT1 GOLGA4 KPNA3 IL24 WDR36 SCAF8 VPS4B LAMB3 RELA CREB1 CREBBP NCOR1 GTF2A1 ARNT MTOR ARID2 FMN2 PAWR RPA2 HERPUD1 | 2.56e-05 | 1420 | 203 | 29 | ctd:D005947 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.62e-05 | 173 | 203 | 9 | 4665_DN | |
| Drug | 2,6-dihydroxybenzoic acid | 2.87e-05 | 175 | 203 | 9 | CID000009338 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.00e-05 | 176 | 203 | 9 | 1212_DN | |
| Drug | C8-ceramide | ACOX1 SPTA1 PSMA5 MAP3K1 NEU2 NRK SYT1 GOLGA4 ANK1 RELA CREB1 CREM ARHGAP4 ARNT PAWR MAP2K5 | 4.19e-05 | 556 | 203 | 16 | CID000002508 |
| Drug | Mal.4 | 4.47e-05 | 72 | 203 | 6 | CID000122821 | |
| Drug | 1-aminoindan | 5.22e-05 | 74 | 203 | 6 | CID000123445 | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 5.23e-05 | 189 | 203 | 9 | 3788_DN | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A | 6.16e-05 | 193 | 203 | 9 | 5839_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 6.41e-05 | 194 | 203 | 9 | 3747_DN | |
| Drug | Retrorsine [480-54-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 6.41e-05 | 194 | 203 | 9 | 2784_DN | |
| Drug | Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 6.66e-05 | 195 | 203 | 9 | 2290_DN | |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 6.66e-05 | 195 | 203 | 9 | 6245_UP | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 6.66e-05 | 195 | 203 | 9 | 6052_DN | |
| Drug | ADP-ribosylarginine | 6.70e-05 | 25 | 203 | 4 | CID000126311 | |
| Drug | Benzbromarone [3562-84-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 6.93e-05 | 196 | 203 | 9 | 5015_DN | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 6.93e-05 | 196 | 203 | 9 | 7425_UP | |
| Drug | Condelphine [7633-69-4]; Down 200; 8.8uM; HL60; HT_HG-U133A | 6.93e-05 | 196 | 203 | 9 | 2976_DN | |
| Drug | Alcuronium chloride [15180-03-7]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 7.21e-05 | 197 | 203 | 9 | 7345_DN | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; HL60; HT_HG-U133A | 7.21e-05 | 197 | 203 | 9 | 2463_DN | |
| Drug | dexamethasone; Down 200; 1uM; MCF7; HG-U133A | 7.21e-05 | 197 | 203 | 9 | 255_DN | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; HL60; HT_HG-U133A | 7.21e-05 | 197 | 203 | 9 | 2483_DN | |
| Drug | Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; HL60; HT_HG-U133A | 7.21e-05 | 197 | 203 | 9 | 1282_UP | |
| Drug | Clopamide [636-54-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 7.21e-05 | 197 | 203 | 9 | 5402_UP | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 7.21e-05 | 197 | 203 | 9 | 5311_DN | |
| Drug | Tomatidine [77-59-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 7.50e-05 | 198 | 203 | 9 | 7166_DN | |
| Drug | genistein; Down 200; 10uM; MCF7; HG-U133A | 7.50e-05 | 198 | 203 | 9 | 638_DN | |
| Drug | Nitrofurantoin [67-20-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 7.50e-05 | 198 | 203 | 9 | 4697_UP | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 7.50e-05 | 198 | 203 | 9 | 5467_DN | |
| Drug | Beta-sistosterol [83-46-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 7.50e-05 | 198 | 203 | 9 | 7332_UP | |
| Drug | Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; HL60; HT_HG-U133A | 7.50e-05 | 198 | 203 | 9 | 3024_DN | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; HL60; HT_HG-U133A | 7.79e-05 | 199 | 203 | 9 | 2357_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 7.79e-05 | 199 | 203 | 9 | 5207_DN | |
| Drug | Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 7.79e-05 | 199 | 203 | 9 | 7009_DN | |
| Drug | Dapsone [80-08-0]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 7.79e-05 | 199 | 203 | 9 | 1705_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; HL60; HT_HG-U133A | 7.79e-05 | 199 | 203 | 9 | 2449_UP | |
| Drug | 2-pyridinecarboxaldehyde N-oxide | 7.91e-05 | 2 | 203 | 2 | CID000556031 | |
| Drug | methylferrocene | 7.91e-05 | 2 | 203 | 2 | CID011984622 | |
| Drug | D-IBS | 8.00e-05 | 10 | 203 | 3 | CID000007228 | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 8.10e-05 | 200 | 203 | 9 | 1682_DN | |
| Drug | cobalt(II) chloride hexahydrate; Down 200; 100uM; MCF7; HG-U133A | 8.10e-05 | 200 | 203 | 9 | 454_DN | |
| Drug | 1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane | 1.09e-04 | 11 | 203 | 3 | ctd:C492909 | |
| Drug | VTCs | 1.19e-04 | 54 | 203 | 5 | CID000006413 | |
| Drug | Pkcs | 1.22e-04 | 211 | 203 | 9 | CID000164073 | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; HL60; HT_HG-U133A | 1.26e-04 | 166 | 203 | 8 | 2525_UP | |
| Drug | Sp 1 (pharmaceutical) | SP1 SP3 SP4 POGZ ITGAX MAP3K1 NFYC TAF4B KPNA4 ZBTB33 RELA CREB1 NCOR1 GTF2A1 SLC20A1 | 1.27e-04 | 548 | 203 | 15 | CID000099040 |
| Drug | Zlllal | PSMA5 KEAP1 MAP3K1 PLIN2 NRK SYT1 GOLGA4 SGCB VPS4B RELA NCOR1 ARNT MTOR SPRED1 NFAT5 TOP2B | 1.31e-04 | 613 | 203 | 16 | CID000107707 |
| Drug | Digitoxigenin [143-62-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.31e-04 | 167 | 203 | 8 | 4801_UP | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.55e-04 | 171 | 203 | 8 | 7535_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.67e-04 | 173 | 203 | 8 | 4565_DN | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 1.74e-04 | 174 | 203 | 8 | 1302_UP | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.74e-04 | 174 | 203 | 8 | 972_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.81e-04 | 175 | 203 | 8 | 3787_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.81e-04 | 175 | 203 | 8 | 4072_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.03e-04 | 178 | 203 | 8 | 1112_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.03e-04 | 178 | 203 | 8 | 7245_DN | |
| Drug | Crotamiton [483-63-6]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 2.11e-04 | 179 | 203 | 8 | 3388_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 2.11e-04 | 179 | 203 | 8 | 4585_DN | |
| Drug | AC1N8GZI | 2.31e-04 | 34 | 203 | 4 | CID004343649 | |
| Drug | homocysteic acid | 2.36e-04 | 3 | 203 | 2 | ctd:C007956 | |
| Drug | cyclohexamine | 2.36e-04 | 3 | 203 | 2 | CID000016622 | |
| Drug | 6-hydroxyuridine | 2.36e-04 | 3 | 203 | 2 | CID000189012 | |
| Drug | AC1MJ1BZ | 2.36e-04 | 3 | 203 | 2 | CID003083813 | |
| Drug | galiellalactone | 2.36e-04 | 3 | 203 | 2 | ctd:C416043 | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; HL60; HT_HG-U133A | 2.37e-04 | 182 | 203 | 8 | 1280_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.46e-04 | 183 | 203 | 8 | 7136_DN | |
| Drug | Cyproterone Acetate | 2.59e-04 | 35 | 203 | 4 | ctd:D017373 | |
| Drug | torcetrapib | HSPH1 SNX13 PHC3 PRRC2C ANK3 EP400 SGCB AHCTF1 CREM SPRED1 LSM14B | 2.65e-04 | 342 | 203 | 11 | ctd:C483909 |
| Drug | Magnetite Nanoparticles | SMG1 GPBP1 FYCO1 ITGAX ITGB7 DHX9 PHC3 GLG1 NAV2 ANKRD12 MAPRE2 GOLGA4 NPAS2 POLR1A ANK3 BAZ2B RELA KANK2 CREBBP IGF2BP2 AKAP9 PTCH2 RIMS2 NFAT5 HERPUD1 | 2.76e-04 | 1310 | 203 | 25 | ctd:D058185 |
| Drug | Cantharidin [56-25-7]; Down 200; 20.4uM; HL60; HT_HG-U133A | 2.84e-04 | 187 | 203 | 8 | 3075_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.84e-04 | 187 | 203 | 8 | 4323_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; PC3; HG-U133A | 2.84e-04 | 187 | 203 | 8 | 448_DN | |
| Drug | tubulin polymerization inhibitor | 2.91e-04 | 142 | 203 | 7 | CID010125800 | |
| Drug | AC1L9FY1 | 2.93e-04 | 101 | 203 | 6 | CID000444218 | |
| Drug | phosalone | 2.94e-04 | 15 | 203 | 3 | CID000004793 | |
| Drug | AC1L1IHP | SP1 PSMA5 MAP3K1 NRK RPS6KA6 SYT1 KIF21A RELA CREB1 CREM NCOR1 ARNT MTOR ATF1 KIF13A MAP2K5 TUBAL3 | 3.00e-04 | 728 | 203 | 17 | CID000004584 |
| Drug | AC1NST48 | BDP1 PGC PLIN2 GLG1 NRK GPC4 SCNN1B GOLGA4 GOLGB1 ANK1 TG ARHGAP4 LMAN1 AKAP9 MTOR | 3.02e-04 | 594 | 203 | 15 | CID005315496 |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 3.16e-04 | 190 | 203 | 8 | 4507_DN | |
| Disease | Prostatic Neoplasms | UNC13D KEAP1 MAP3K1 USP7 POLK ABCG5 MED12 GOLGA4 IL24 CREBBP NCOR1 FOXP4 KMT2D ARID2 PAWR HERPUD1 TJP3 | 1.02e-06 | 616 | 198 | 17 | C0033578 |
| Disease | Malignant neoplasm of prostate | UNC13D KEAP1 MAP3K1 USP7 POLK ABCG5 MED12 GOLGA4 IL24 CREBBP NCOR1 FOXP4 KMT2D ARID2 PAWR HERPUD1 TJP3 | 1.02e-06 | 616 | 198 | 17 | C0376358 |
| Disease | obsolete_red blood cell distribution width | SP1 SP3 SPTA1 UNC13D ITGAX PGC MAP3K1 SNX13 PLIN2 PRRC2C NUFIP2 NFRKB ANKRD12 POLK MAPRE2 FNDC3B POLR1A ANK1 EP400 BAZ2B MRPL28 CPS1 KANK2 IGF2BP2 HELZ2 | 4.32e-06 | 1347 | 198 | 25 | EFO_0005192 |
| Disease | Malignant neoplasm of breast | SLCO2B1 KEAP1 MAP3K1 NFYC SCNN1B HERC2 MED12 RUSF1 GOLGB1 IL24 FNDC3B ANK1 RELA NCOR1 GTF2A1 FOXP4 KMT2D LLGL2 AKAP9 CLCA2 MTOR | 1.24e-05 | 1074 | 198 | 21 | C0006142 |
| Disease | Bladder Neoplasm | 4.66e-05 | 140 | 198 | 7 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 4.88e-05 | 141 | 198 | 7 | C0005684 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 6.63e-05 | 63 | 198 | 5 | EFO_0022335 | |
| Disease | Schizophrenia | SOX5 SP1 SP4 TRRAP NUFIP2 MED12 NPAS2 KPNA3 ANK3 ADNP2 RELA CREB1 PKNOX2 IGF2BP2 MTOR PAWR RIMS2 | 1.04e-04 | 883 | 198 | 17 | C0036341 |
| Disease | body mass index, type 2 diabetes mellitus | 1.56e-04 | 16 | 198 | 3 | EFO_0004340, MONDO_0005148 | |
| Disease | mean corpuscular hemoglobin concentration | SOX5 SP1 SPTA1 GON4L SNX13 ANKRD12 RUSF1 GOLGB1 FNDC3B POLR1A ANK1 EP400 COBLL1 MRPL28 POU6F1 CPS1 CREB1 GTF2A1 UBE3C | 1.76e-04 | 1105 | 198 | 19 | EFO_0004528 |
| Disease | Intellectual Disability | CNKSR1 GON4L POGZ QRICH1 TRRAP BPTF SYT1 PUF60 MTOR ZNF335 PUM1 | 2.35e-04 | 447 | 198 | 11 | C3714756 |
| Disease | hereditary spherocytosis type 1 (implicated_via_orthology) | 2.66e-04 | 4 | 198 | 2 | DOID:0110916 (implicated_via_orthology) | |
| Disease | Clear Cell Sarcoma of Soft Tissue | 2.66e-04 | 4 | 198 | 2 | C0206651 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 4.35e-04 | 264 | 198 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | hereditary spherocytosis (is_implicated_in) | 4.42e-04 | 5 | 198 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Malignant Cystosarcoma Phyllodes | 4.42e-04 | 5 | 198 | 2 | C0600066 | |
| Disease | Hereditary spherocytosis | 4.42e-04 | 5 | 198 | 2 | cv:C0037889 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 4.42e-04 | 5 | 198 | 2 | C0221409 | |
| Disease | Phyllodes Tumor | 4.42e-04 | 5 | 198 | 2 | C0010701 | |
| Disease | triglyceride measurement, phospholipid measurement | 4.71e-04 | 146 | 198 | 6 | EFO_0004530, EFO_0004639 | |
| Disease | cancer (implicated_via_orthology) | 4.80e-04 | 268 | 198 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | apolipoprotein B measurement | ANKRD31 SP1 SP4 PSMA5 RRBP1 BPTF NUFIP2 MAPRE2 ABCG5 ANK1 COBLL1 KANK2 HERPUD1 | 5.77e-04 | 663 | 198 | 13 | EFO_0004615 |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 7.85e-04 | 222 | 198 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 8.27e-04 | 224 | 198 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 8.49e-04 | 225 | 198 | 7 | EFO_0008317, EFO_0020947 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 8.60e-04 | 63 | 198 | 4 | EFO_0022239 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 8.61e-04 | 28 | 198 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | multiple myeloma | 9.71e-04 | 112 | 198 | 5 | EFO_0001378 | |
| Disease | diabetes mellitus | 1.15e-03 | 68 | 198 | 4 | EFO_0000400 | |
| Disease | coronary artery disease | ANKRD31 UNC13D QRICH1 RRBP1 MAP3K1 SNX13 MAPRE2 ADGRL3 FNDC3B KANK2 IGF2BP2 SF3B3 ZNF335 CARF FMN2 PAWR NFAT5 HERPUD1 | 1.20e-03 | 1194 | 198 | 18 | EFO_0001645 |
| Disease | Hereditary spherocytosis | 1.22e-03 | 8 | 198 | 2 | C0037889 | |
| Disease | Large cell carcinoma of lung | 1.28e-03 | 32 | 198 | 3 | C0345958 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 1.36e-03 | 315 | 198 | 8 | EFO_0004574, EFO_0004612 | |
| Disease | Creutzfeldt Jacob Disease | 1.56e-03 | 9 | 198 | 2 | EFO_0004226 | |
| Disease | Chronic schizophrenia | 1.56e-03 | 9 | 198 | 2 | C0221765 | |
| Disease | Hepatic Insufficiency | 1.56e-03 | 9 | 198 | 2 | C1306571 | |
| Disease | neuroticism measurement, cognitive function measurement | SOX5 GATB TSC22D2 MED24 NAV2 SYT1 NPAS2 MMS22L PCDHA12 CREB1 TG | 1.63e-03 | 566 | 198 | 11 | EFO_0007660, EFO_0008354 |
| Disease | Drugs used in diabetes use measurement | 1.74e-03 | 255 | 198 | 7 | EFO_0009924 | |
| Disease | cortical surface area measurement | SOX5 SP1 CPAMD8 SP4 MYCBP2 PLXND1 TSC22D2 MAP3K1 SNX13 PRRC2C NAV2 SYT1 MAPRE2 ANK3 BAZ2B CPS1 TG NCOR1 PAWR | 1.86e-03 | 1345 | 198 | 19 | EFO_0010736 |
| Disease | Unipolar Depression | 1.90e-03 | 259 | 198 | 7 | C0041696 | |
| Disease | abdominal aortic calcification measurement | 1.95e-03 | 10 | 198 | 2 | EFO_0010272 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 2.28e-03 | 39 | 198 | 3 | EFO_0022332 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.38e-03 | 200 | 198 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | metabolic syndrome | 2.38e-03 | 200 | 198 | 6 | EFO_0000195 | |
| Disease | intraocular pressure measurement | TSC22D2 FAM186A ADAMTS17 HERC2 NPAS2 FNDC3B KANK2 OR4C15 MTOR PTCH2 | 2.43e-03 | 509 | 198 | 10 | EFO_0004695 |
| Disease | neutrophil count | SP1 CPAMD8 MYCBP2 PSMA5 UBQLN4 POGZ PGC SNX13 MED24 GLG1 FAM186A NUFIP2 SYT1 MAPRE2 PCDHA12 CPS1 CREBBP GTF2A1 MAP2K5 | 2.52e-03 | 1382 | 198 | 19 | EFO_0004833 |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.76e-03 | 206 | 198 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | Secondary Open Angle Glaucoma | 2.83e-03 | 12 | 198 | 2 | C0271148 | |
| Disease | Glaucoma, Open-Angle | 2.83e-03 | 12 | 198 | 2 | C0017612 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 2.83e-03 | 12 | 198 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | hemoglobin A1 measurement | SPTA1 UNC13D PLXND1 ZNF236 ITGAX FNDC3B ANK1 COBLL1 IGF2BP2 UBE3C | 2.83e-03 | 520 | 198 | 10 | EFO_0007629 |
| Disease | cognitive function measurement, self reported educational attainment | 2.86e-03 | 355 | 198 | 8 | EFO_0004784, EFO_0008354 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.93e-03 | 144 | 198 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.02e-03 | 145 | 198 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | hair colour measurement | SOX5 UNC13D MAP3K1 SNX13 HERC2 BPIFA2 KMT2D FMN2 ZNF76 PAWR RPL3 | 3.08e-03 | 615 | 198 | 11 | EFO_0007822 |
| Disease | non-high density lipoprotein cholesterol measurement | SP1 CNKSR1 SPTA1 KEAP1 BPTF NUFIP2 MAPRE2 COBLL1 ADNP2 KANK2 PHC1 HERPUD1 | 3.31e-03 | 713 | 198 | 12 | EFO_0005689 |
| Disease | Glaucoma, Primary Open Angle | 3.33e-03 | 13 | 198 | 2 | C0339573 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.43e-03 | 45 | 198 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.63e-03 | 291 | 198 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | phospholipids:total lipids ratio | 4.43e-03 | 227 | 198 | 6 | EFO_0020946 | |
| Disease | Lymphoma, Follicular, Grade 2 | 4.44e-03 | 15 | 198 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 4.44e-03 | 15 | 198 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 4.44e-03 | 15 | 198 | 2 | C1956130 | |
| Disease | Autosomal recessive primary microcephaly | 4.44e-03 | 15 | 198 | 2 | cv:C3711387 | |
| Disease | Lymphoma, Large-Cell, Follicular | 4.44e-03 | 15 | 198 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 4.44e-03 | 15 | 198 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 4.44e-03 | 15 | 198 | 2 | C0079758 | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 4.44e-03 | 15 | 198 | 2 | OBA_2045067 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 4.63e-03 | 50 | 198 | 3 | EFO_0022303 | |
| Disease | Psychotic Disorders | 4.84e-03 | 101 | 198 | 4 | C0033975 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 4.89e-03 | 51 | 198 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 4.89e-03 | 51 | 198 | 3 | EFO_0022285 | |
| Disease | Diabetic Angiopathies | 5.05e-03 | 16 | 198 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 5.05e-03 | 16 | 198 | 2 | C0025945 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 5.29e-03 | 312 | 198 | 7 | EFO_0004612, EFO_0010351 | |
| Disease | Huntington's disease (is_marker_for) | 5.45e-03 | 53 | 198 | 3 | DOID:12858 (is_marker_for) | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 5.45e-03 | 53 | 198 | 3 | EFO_0022340 | |
| Disease | testosterone measurement | SOX5 UBQLN4 UNC13D TSC22D2 PLIN2 FAM186A NUFIP2 USP7 MED12 GTF2A1L POLR1A ANK3 COBLL1 LAMB3 CREB1 PKNOX2 ARNT | 5.68e-03 | 1275 | 198 | 17 | EFO_0004908 |
| Disease | Small cell carcinoma of lung | 5.74e-03 | 54 | 198 | 3 | C0149925 | |
| Disease | neuroimaging measurement | SOX5 SP1 PLXND1 TSC22D2 MAP3K1 PLIN2 PRRC2C NAV2 SYT1 ROBO3 MAPRE2 ANK3 CREB1 TG NCOR1 | 5.88e-03 | 1069 | 198 | 15 | EFO_0004346 |
| Disease | body fat percentage | 5.93e-03 | 488 | 198 | 9 | EFO_0007800 | |
| Disease | Major Depressive Disorder | 6.13e-03 | 243 | 198 | 6 | C1269683 | |
| Disease | cholesterol to total lipids in large LDL percentage | 6.35e-03 | 56 | 198 | 3 | EFO_0022235 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 6.35e-03 | 56 | 198 | 3 | EFO_0022250 | |
| Disease | PR interval | 6.48e-03 | 495 | 198 | 9 | EFO_0004462 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 6.67e-03 | 57 | 198 | 3 | EFO_0022284 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IPGATLLQQNDQQLV | 731 | Q8WWZ7 | |
| SGQLAPRQQQQQTEL | 496 | P27540 | |
| PQISSIIQGQLVQQQ | 266 | Q96L91 | |
| SQQQPFQQALAGSLV | 476 | Q96L91 | |
| LQFAQQPQVVEAQTQ | 611 | Q96L91 | |
| QGPAAVQQKITAQQI | 2986 | Q96L91 | |
| GVNNLLENATVQAGP | 476 | A6H8Y1 | |
| NIINPQDLTVNLVAN | 2261 | A6H8Y1 | |
| QDLTVNLVANVPQDG | 2266 | A6H8Y1 | |
| SNQTPQILVKNAGIQ | 2791 | Q99996 | |
| RGNVLQFVQEPQAQQ | 26 | Q8N9T2 | |
| NHQPNGVIQSVIQEA | 491 | Q9UIF8 | |
| VVQGNEFQNIPGEQV | 1796 | P16157 | |
| VETVNNLLQPQALNA | 626 | Q9HAR2 | |
| VQGQTPAQQLLVGQQ | 1111 | Q68CP9 | |
| PAQQLLVGQQNVQLV | 1116 | Q68CP9 | |
| ADSTPNIQQALQQRI | 2281 | Q92793 | |
| SQNGTIVNGKQILQP | 476 | Q8N302 | |
| AGADPQQVINIDQIR | 356 | O75879 | |
| PLALEQIQGNVQANV | 106 | Q96AZ1 | |
| NQEPGILQQKNAVQI | 1516 | Q6UB98 | |
| IELVNAGANVNQPND | 256 | Q8NB46 | |
| SQVVAQIQAQQSGVP | 2576 | Q12830 | |
| SLGPNQENVVQNEII | 511 | Q53SF7 | |
| LGQEQVLIQPLNNSQ | 156 | Q8TE56 | |
| VVPVNQGVNSGVLQL | 531 | Q6IQ32 | |
| QLNQTVGTNILPVNQ | 566 | Q6IQ32 | |
| QLGQENPQLLQQISR | 261 | P54725 | |
| QNTIQNEAVNLLDPG | 196 | Q96IZ0 | |
| PHQQIQAQLVAGQSL | 191 | Q2TAL8 | |
| QVNNLGQRDLPVSIN | 956 | P20702 | |
| AENQPANQNAAPQVV | 221 | Q15011 | |
| EAQVPQGNIDQVAVV | 256 | Q8NHS3 | |
| QLQQRSAAVTQPQLG | 566 | Q99743 | |
| AAEILLQNGANPNQK | 1236 | Q8N7Z5 | |
| LTAELLQQGANPNLQ | 506 | Q9P2R3 | |
| VLLGLSQNPNVQEIV | 11 | Q8NGM1 | |
| GNQQQVQAVIDAGLI | 356 | O00505 | |
| PAEAQQAQQVQRIIS | 1691 | Q14667 | |
| QENNAVTQIHLLPGQ | 71 | Q6P1M3 | |
| QQQGQATQVRIQTVP | 1251 | Q6P4R8 | |
| TQVILQLQPVQQGLF | 31 | Q9Y692 | |
| NNSPQPQNVVFDVQI | 96 | P19823 | |
| INLLVQNQQTPNSAI | 306 | Q86T24 | |
| EIPQENGNASVISQQ | 351 | Q86WP2 | |
| LANQGNNPEVQVDTS | 441 | O75487 | |
| EEQQQLQQALAPAQA | 11 | Q13439 | |
| PQNIERLNGQGVCQI | 3196 | O95714 | |
| ELPSVNIGAFVNQNQ | 186 | Q6ZRQ5 | |
| PGLQAQLAQAEQRAQ | 976 | Q9BQS8 | |
| ARQQFLEQSLQPGLQ | 46 | Q8WXT5 | |
| VQPAAVQAQGQVNDE | 201 | Q9BX40 | |
| ANQGFPAVQLADAQV | 2426 | Q2LD37 | |
| VQQDNSEAGTQPQVQ | 531 | Q92598 | |
| QQLGVEVPEAHQLQQ | 896 | Q9BY66 | |
| AQVIIPQGQLVDVNS | 126 | Q8N187 | |
| QAPNIQLSIGVKNQA | 341 | Q86SJ6 | |
| ATNAILQPNQEALLQ | 201 | Q6ZQW0 | |
| QLPITIQVGNFNQTI | 1246 | Q9Y4D7 | |
| EQQVNGQLIEPLQIF | 91 | Q13163 | |
| TQAKPLQGQTLQGQV | 1176 | Q6ZU69 | |
| NQPVTEQEILNIFQG | 616 | Q9H0H0 | |
| TQDGPSAQILQQLVV | 961 | Q9H6R4 | |
| QGAQAGQVDPLQLQT | 101 | A1E959 | |
| QAVTPQLLLNAQGQV | 41 | Q14863 | |
| LEQGGILPQNIQDQN | 381 | Q8IV20 | |
| NNPAIVIIGNNGQIH | 161 | P49257 | |
| GVRSTAILPEQQQQQ | 2041 | Q93074 | |
| NLQRQGLVSLQPNQA | 196 | Q8IVH2 | |
| SANVLPIVQINGNAA | 406 | Q9UK32 | |
| AQLVGPAQSGLLQQQ | 36 | Q9NX70 | |
| VNQQANLIPGLNLSA | 356 | Q9Y6M1 | |
| NATNIELATVQPGQN | 211 | P28066 | |
| INIPQVQASQPAEVN | 321 | Q9Y5B6 | |
| AAQAQQAHVQAPQIG | 96 | Q9H422 | |
| NPIADAQNLSQETQG | 1076 | O94916 | |
| VQPEILSQGQVLVQN | 526 | Q8NDX5 | |
| FTLAQQPTAVQVQGQ | 146 | Q13952 | |
| GEGQQVQIVQAQPQG | 196 | Q13952 | |
| VQIVQAQPQGQAQQA | 201 | Q13952 | |
| TNTGEIQQIPVQLNA | 231 | Q13952 | |
| QEAQNPNLVSQLCGV | 36 | P35410 | |
| VGQNPQDVVQAIVNV | 231 | Q9NYR8 | |
| GQQEVLQDQPLSQGA | 101 | P26010 | |
| GQVAQALSAANIQPI | 331 | P26010 | |
| NQNQQGQQTDPLVAA | 516 | Q14671 | |
| QAQPIVPVQRAAEQQ | 606 | Q8IV76 | |
| AVVAQELPSNDQLQQ | 26 | Q5JUK9 | |
| SGITELVNNVLQPQQ | 66 | Q9UQ26 | |
| PGQVTEQQQLQTRAN | 106 | Q9Y3R4 | |
| LPNDTLSVENGVINQ | 3211 | Q9P2D7 | |
| QQALQTLIQETDPGA | 481 | Q92896 | |
| NDLPSQRIQPQQVAV | 456 | Q15067 | |
| RGQNQPVLNITNKQA | 316 | P31327 | |
| LGTELVQQQEQQPAS | 311 | P17658 | |
| SLDVNVIQQVVDNPQ | 226 | Q96DR5 | |
| QDLQNPGGNRITQVQ | 171 | Q5T0U0 | |
| DQNGNPLPNVIVEVQ | 321 | P14384 | |
| QENSKLNAEVQGQQP | 836 | Q8IW35 | |
| NGDAAQQVILVQVNP | 31 | Q53EP0 | |
| TVQAQLVAQGEPVVQ | 61 | Q8IZJ3 | |
| LAAEQQPGNQAQAQA | 1166 | Q9BV73 | |
| ANNFVLIVSQLQPSQ | 141 | Q13007 | |
| QGAQPQTFNIISQQL | 2171 | Q3T8J9 | |
| VAVLGGNIKQNPNTQ | 471 | Q92771 | |
| LGIVQNPNIVNSVVA | 521 | Q9H222 | |
| VLLQNNASPNELTVN | 781 | Q12955 | |
| AQTTDGQQILVPSNQ | 211 | P16220 | |
| GQQILVPSNQVVVQA | 216 | P16220 | |
| QTLSPNGENNNDIIQ | 6 | Q15555 | |
| NITVQENQSAGQPIF | 171 | Q8IXH8 | |
| QELQAAQARQADPQP | 301 | Q63ZY3 | |
| VQQLDPSNAIGIANF | 176 | Q14145 | |
| QSQNDVNPVSLQLDL | 96 | Q13751 | |
| SDVRGLSQNQQIPQN | 1791 | Q8WYP5 | |
| QEVGITLTPQQAQAQ | 1081 | A6NE01 | |
| QDQAPGISLTTQQAQ | 1151 | A6NE01 | |
| PQQAQALGITLTLQQ | 1221 | A6NE01 | |
| QQAQAQEITLTPQQA | 1426 | A6NE01 | |
| QAQELGITLTPQQAQ | 1451 | A6NE01 | |
| QALGISLTPQQAQAQ | 1621 | A6NE01 | |
| QAQAQGITLTPQQAQ | 1631 | A6NE01 | |
| PNQVNVAVTRAQEGL | 2591 | Q9BYK8 | |
| VQTQTGQNSIPALAQ | 26 | Q03060 | |
| QQQQQLQGAEEPAAP | 221 | Q9NZ56 | |
| VAQILQSPQGQQLQQ | 191 | Q9UPN6 | |
| AVQLPNGNLVQFSQA | 351 | Q8WUM9 | |
| LQATNIFAQVPQQEL | 221 | P51168 | |
| KNNEISVIQNGGIPQ | 1226 | Q9BXA9 | |
| ADINGQNPNIQVTIE | 116 | B1AKI9 | |
| VVTQAIPQGAIQIQN | 256 | Q96KN3 | |
| IPQGAIQIQNTQVNL | 261 | Q96KN3 | |
| SAQLPLQGDVALVQQ | 126 | Q13474 | |
| AQFEPSQRQNQVGVV | 316 | Q08211 | |
| VQIQITVLDVNDNGP | 226 | Q9UN75 | |
| QQGGVTAVQLQTEAQ | 26 | P23511 | |
| GQQVQTLQVVQGQPL | 46 | P23511 | |
| QIIIQQPQTAVTAGQ | 131 | P23511 | |
| QIAVQGQQVAQTAEG | 151 | P23511 | |
| QPVNADGTILQQVTV | 171 | P23511 | |
| AVQPQQSNALVGLLG | 321 | P42345 | |
| TLNSNDPVQNVVQVL | 591 | Q9H1H9 | |
| RAAQQQTVQQQPLAG | 516 | Q13233 | |
| PQVQALQQLQGAARV | 401 | Q7Z2Y5 | |
| LVNPNGQKQQLVDAF | 486 | Q9Y2M0 | |
| SQNQVQVVLNQKAGP | 361 | Q96GQ5 | |
| ENPLQVLVNAIINSG | 106 | P46782 | |
| NNQLLVGIIQAAELP | 156 | P21579 | |
| QVKQLVVQQPSGGNE | 526 | Q92750 | |
| GANIIDEPLQQVIQF | 96 | Q9Y5W8 | |
| PGENQATGQQQIIID | 61 | Q02446 | |
| QIIIDPSQGLVQLQN | 71 | Q02446 | |
| QPQQLELVTTQLAGN | 86 | Q02446 | |
| SGNILAQNLANQTVP | 216 | Q02446 | |
| NVQELRQAVINGPNV | 476 | O95602 | |
| FVGSNNINLLQPIGQ | 796 | Q02880 | |
| SNIGQAQPIIDQLAE | 206 | Q9UHX1 | |
| QLQVNDNTQGPRAAL | 26 | Q6ZMZ3 | |
| DLSQFQTQTQPLVGQ | 576 | O75157 | |
| QNALQQVVARQGRPV | 621 | Q06210 | |
| LEQQVPVNQVFGQDE | 201 | P39023 | |
| ARQQFLEQSLQPGLQ | 46 | Q5VV16 | |
| QQIGATNVPLEAINE | 666 | O60841 | |
| LVTLIANNNAGNPLV | 86 | Q7Z3K3 | |
| QLAQEALPENASQQI | 361 | Q9Y6C5 | |
| VVAQQINAQRPEPQS | 861 | O75376 | |
| DQNTVNGPVQIVNVK | 3051 | Q96Q15 | |
| LSPQGLILQGQEQQV | 611 | Q16819 | |
| KSGENANIQPNIQLI | 396 | O75448 | |
| AQAAINGVINTPELN | 1766 | Q8IVL1 | |
| VNNVAQEPVNTLGDI | 1461 | Q9Y520 | |
| LQALLNVLQGQQPEG | 226 | O75592 | |
| LQGIDSQCVNQPEQL | 246 | Q9H9Q4 | |
| QPNGVVLDTQQDQLE | 31 | A6NHL2 | |
| RNENLVITGNNQPIV | 131 | Q16585 | |
| VITGNNQPIVFQQGT | 136 | Q16585 | |
| SGQIQIIPGANQQII | 201 | P08047 | |
| LLQQAVPLQGLANNV | 231 | P08047 | |
| IQPQLVQGGQALQAL | 401 | P08047 | |
| VQGGQALQALQAAPL | 406 | P08047 | |
| SQETLQNLQLQAVPN | 431 | P08047 | |
| NLQVQNPQAQTITLA | 471 | P08047 | |
| QDPVALQGRVNQLVQ | 671 | P98171 | |
| VDQGLFVQLVQANTP | 126 | Q9H190 | |
| QAFPAQQLLNVNLTG | 701 | P0C7V6 | |
| DGQQILVPSNQVVVQ | 156 | P18846 | |
| NGLLIAINPQVPENQ | 41 | Q9UQC9 | |
| QIQPGDEVVQINEQV | 236 | Q969H4 | |
| PVQQILTNSGQLLQV | 151 | P52655 | |
| LQNQLQGAIVIERPN | 116 | O75351 | |
| QVNQVTPDQLGNISL | 1216 | A0JNW5 | |
| FGQSNVNIAQQVVIG | 51 | Q14186 | |
| NPPDLQQQVQAAAAA | 456 | Q8TF68 | |
| PQQHVLERQVQLSQG | 106 | Q8IXZ2 | |
| TVILPGTNSQNQRIN | 406 | O00295 | |
| ASIQSEPGQQNLLVQ | 3041 | Q8N2C7 | |
| PANGLTVAQNQVLNL | 201 | P15927 | |
| QLENGPNTQLARLQQ | 786 | Q9P2E9 | |
| ATNPISRVLNGNQQV | 116 | Q7Z417 | |
| AQVDLPSQTDQQNLG | 486 | Q7Z417 | |
| QSIQVPNQEFGLSEN | 151 | P20142 | |
| QELQAVAQQFSLPQE | 206 | Q8N271 | |
| QDGLVQIAPNLTVIQ | 341 | O94956 | |
| QQVFQQLGQPSVIQT | 156 | Q9UNN4 | |
| AIPSGENQINQIALN | 1446 | Q7Z4S6 | |
| ENQINQIALNPTGTF | 1451 | Q7Z4S6 | |
| NLTNQIQIIPGTNQA | 151 | Q02086 | |
| NIIQAGNNLLIVQSP | 276 | Q02086 | |
| QVIPQIQSADGQQVQ | 171 | Q02447 | |
| SANIQNLIPQTGQVQ | 221 | Q02447 | |
| NLIPQTGQVQVQGVA | 226 | Q02447 | |
| QPVSNVRAIQANINI | 6 | Q9UHP9 | |
| QANQITFGQPGLDIQ | 191 | Q7Z699 | |
| PGTQIQIKVQAQGQE | 736 | Q96MS0 | |
| LNQEVAGPRNAQIQA | 116 | Q96GC6 | |
| PTQQQRQVQLDAQAA | 26 | Q9H0E2 | |
| IQFQNNGVVDDSQLP | 66 | A0A584 | |
| FEEQNNPQILQNSVV | 271 | Q9UBT6 | |
| QNLAVRNQQASAQGP | 206 | P78364 | |
| QEAAGKQQQQLPQTL | 176 | Q6NWY9 | |
| QQLQQQALSEPAVVQ | 236 | Q13084 | |
| VGQQIVIIQAANQNP | 576 | Q68DE3 | |
| QQQQAAPVEGVAGEQ | 966 | P02549 | |
| PIQGNTLDLVQLEQN | 871 | Q15393 | |
| QNLPGFQNSQETVEV | 1481 | Q8N9V7 | |
| QEGDQILQVNDVPFQ | 421 | O95049 | |
| QLQLAANLVGPNVQI | 1361 | Q9UL36 | |
| HTLLSNIQGVPQNIQ | 326 | Q99541 | |
| NVGQQAQIPIATAGV | 661 | P35711 | |
| QNVEGQNLQEQVCPE | 26 | Q13342 | |
| GLNPDVVQNIQDICN | 206 | Q7Z2W4 | |
| NSEFQQLLNQGIPVA | 471 | Q04206 | |
| PGQQLVTQAQLEAAA | 1281 | Q9H4Z2 | |
| QIQQGLQTLQTEAPG | 471 | Q9NRR5 | |
| FSPVDLNQVIVNGNQ | 1856 | P01266 | |
| ITQNPVINGNVALSD | 36 | Q93009 | |
| IELQEAAQINAGLQP | 2941 | Q9Y4A5 | |
| QRVGAVLEQGQLQNT | 726 | Q70J99 | |
| PQVALITQDGAQQVS | 431 | P36508 | |
| DQQEIQVLISGAQVP | 956 | Q15386 | |
| QNNDPQQSKVVNLGV | 806 | Q8NI36 | |
| QVLGKQNGNITQIPE | 211 | Q3MJ62 | |
| QVQELQAGPLNIDVA | 3096 | Q14789 | |
| GNQQQVQAVIDANLV | 356 | O00629 | |
| VAIQQQQQQGPGVQT | 3751 | O14686 | |
| QVNGQVVPEASQLSI | 4401 | O14686 | |
| AIEQQLLQPQAETGS | 11 | Q9BZK3 |